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Titre : Imagerie IRTF tridimensionnelle pour l’étude de 
l’insuffisance rénale chronique 
Résumé : 
L’insuffisance rénale chronique (IRC) et l’une des pires maladies chroniques dans les 
pays développés. Les grades de l’IRC sont principalement basés sur la mesure ou 
l’estimation du taux de filtration rénale (GFR). Cependant, cette méthode est peu sensible 
sur les premiers stades de la pathologie et n’apporte donc pas de valeur diagnostique. La 
détection de la pathologie à des stades précoces et son traitement peuvent éviter ou 
limiter les effets délétères de la chronicité. Cette thèse se penche sur le développement 
de la microscopie IRTF en tant qu’outil diagnostic pour l’identification par histopathologie 
à l’échelle du glomérule dans un modèle d’IRC. Nous avons développé la technique de 
reconstruction 3D pour l’imagerie IRTF des modifications biochimiques à l’échelle du 
glomérule pour déterminer des marqueurs de l’IRC. La déconvolution spectrale et le 
clustering sont appliqués après analyses IRTF pour distinguer les modèles sains et 
pathologiques. Ensuite, la microvasculature glomérulaire est révélée par agent de 
contraste pour en déterminer les anomalies morphologiques. Grâce aux résultats obtenus 
en 3D et l’utilisation de méthodes statistiques avancées, la microscopie IRTF est utilisée 
comme une technique fonctionnelle pour déterminer les modifications morphologiques et 
moléculaires apparaissant au cours du développement de l’IRC. 
 
Mots clés : IRFT, insuffisance rénale chronique, microscopie, histopathologie 
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Title : THREE-DIMENTIONSAL INFRARED IMAGING FOR 
CHRONIC KIDNEY DISEASE INVESTIGATION 
Abstract :  
CKD (Chronic Kidney Disease) is one of the worst public diseases in developing countries. 
The stages of CKD are mainly based on measured or estimated GFR (Glomerular 
Filtration Rate). However, this method is not sensitive enough on early stages of the 
pathology and thus do not offer accurate diagnostic value. Early detection and treatment 
can often limit or avoid the chronicity effects of the disease. This thesis focuses on the 
development of FTIR microscopy as a diagnostic tool for the identification by 
histopathology at glomerulus level of the kidney in CKD model. We developed a technique 
of 3D reconstruction for the FTIR imaging of biochemical components changes in 
glomeruli for identifying the pathological marker of CKD. The curve-fitting and spectral 
clustering are applied on the FTIR microscopy analysis to distinguish between healthy 
and pathological glomeruli of a kidney. Then, the glomerular microvasculature is 
highlighted to reveal the morphological abnormalities by perfusing contrast agents into 
blood vessels. With advanced 3D statistical methods and 3D image visualization by 
microscopy, FTIR spectro-imaging can be used as a functional technique to determine the 
morphological and molecular changes occurring along CKD development. 
 
 
 
 
Keywords : FTIR, CKD, glomeruli, histopathology 
 
Unité de recherche 
LAMC , Inserm U1029, Allée Geoffroy Saint-Hillaire, 33600 Pessac  
4 
 
 
 
PhD Thesis 
 
 
PRESENTED AT THE UNIVERSITY OF BORDEAUX 
DEPARTMENT OF LIFE SCIENCE 
 
 
THREE-DIMENTIONAL INFRARED IMAGING FOR CHRONIC 
KIDNEY DISEASE INVESTIGATION 
 
 
by HSIANG-HSIN CHEN 
To obtain the title of doctor 
  
5 
 
Acknowledgements 
This work would not be possible without the support and encouragement of the professors and colleagues 
in Bordeaux and Taiwan, whose much inspiring presence has deeply enriched my years in the University of 
Bordeaux. 
 
Firstly and foremost, I would like to thank my supervisor, Dr. Cyril Petibois, for his support, encouragement, 
and guidance during my study. His mastery of spectroscopic imaging and his strong enthusiasm for scientific 
enterprise have been inspirational role-model to me in the rest of my research path. 
 
I would also like to thank Professor Sophie Lecomet and Andreas Bikfalvi for giving me the opportunity to 
study my PhD project in CBMN and U1029 research groups, respectively, throughout the period of this work. 
Their valuable support is the precious part of my PhD study to be deeply acknowledged. 
 
In particular, I would like to thank Dr. Yeukuang Hwu, the senior researcher of Institute of Physics in 
Academia Sinica, Taiwan for his precious comments, support and helps during my PhD study. I would like 
to say special thanks to the colleagues of his group for their availability, encouragements and helps about 
my work. I also pay my deepest gratitude to Dr. Ann Chen, Doctor of Tr-iservice Hospital in Taiwan, and his 
group members for the collaboration of work and helps in our research by providing the tissue samples. 
 
I would also like to say my deepest thanks to Prof. Gaétan Laroche, Universite Laval, Canada, and Prof. 
Michel Moenner, Universite de Bordeaux, for generously providing their time and valuable suggestions in 
evaluating my thesis as the jury of my thesis defense. I am very grateful to Prof. Sophie Javerzat, Universite 
de Bordeaux for accepting be the referee, detailed reading my thesis. I would like to say special thanks to 
Prof. Chia-liang Cheng for his time out of his busy schedule and suggestions about my thesis. 
 
Sincere thanks to members of my research group for being my loved friends and trusted allies as well as 
providing their patience and efforts about the experiment preparation and statistical discussions of my data 
6 
 
analysis problems. 
 
Special thanks to my friends in Bordeaux whom made my life at the University of Bordeaux richer and livelier. 
 
Finally, I would like to express my sincerest thanks and gratitude to my family in Taiwan who have provided 
their deep love and encouragement throughout my PhD work. Despite being thousands of miles away, they 
have been an integral part of my life and I owe it all to them. 
7 
 
Three-dimensional Infrared Imaging for Chronic Kidney Disease 
Investigation 
Table of Contents 
List of Figures ................................................................................................................................. 9 
List of Tables ................................................................................................................................. 11 
List of Abbreviations .................................................................................................................... 12 
Introduction ................................................................................................................................... 14 
CKD prevalence ....................................................................................................................... 14 
General information about the kidney .................................................................................. 15 
The kidney’s function and body homeostasis ..................................................................... 16 
Defining chronic kidney disease ............................................................................................ 18 
Renal failure in CKD ................................................................................................................ 19 
Glomerular patho-physiology ................................................................................................. 20 
Degenerative glomerular efficiency ...................................................................................... 21 
Glomerular importance in CKD ............................................................................................. 22 
Justification of GFR and other markers of the kidney in clinical and experiment studies
 .................................................................................................................................................... 23 
The clearance rate of endogenous plasma substrates in blood and urine ................ 25 
Bioimaging approaches for CKD ........................................................................................... 25 
X-ray computer tomography .............................................................................................. 26 
Magnetic resonance imaging based morphometric analysis of glomeruli in whole 
kidney .................................................................................................................................... 27 
Renal ultrasonography morphology .................................................................................. 29 
Microscopy techniques in histology .................................................................................. 30 
Hematoxylin and Eosin (H&E) staining as a basic tool for histopathology ................. 30 
Fluorescent imaging of glomeruli for functional study ................................................... 31 
Alternative method: Morphological visualization of glomerular vasculature by 
corrosion casting-based investigation .............................................................................. 32 
Clinical imaging techniques for evaluating renal function in CKD ................................... 34 
Emerging technique: Infrared spectral imaging in biochemical analysis ........................ 35 
General information of IR spectromicroscopy ................................................................. 35 
FTIR spectral information in biological samples ............................................................. 36 
8 
 
FTIR imaging system .......................................................................................................... 37 
Biomedical application of FTIR imaging ........................................................................... 39 
The art of 3D FTIR imaging technique on histopathology............................................. 40 
Why combine X-Ray tomography and FTIR imaging for CKD analysis? ................... 40 
Objectives ..................................................................................................................................... 42 
Methodology ................................................................................................................................. 43 
Animal experiments ................................................................................................................. 43 
Imaging contrast agents ......................................................................................................... 43 
FTIR imaging ............................................................................................................................ 44 
Data acquisitions ................................................................................................................. 44 
Spectral interval absorptions ............................................................................................. 45 
Statistical analyses on spectra .......................................................................................... 45 
Classical cluster analysis ................................................................................................... 46 
Curve fitting ........................................................................................................................... 46 
3D FTIR image reconstructions ............................................................................................. 47 
Results ........................................................................................................................................... 48 
Publication No. 1: ..................................................................................................................... 49 
Title: the future of infrared spectroscopy in biosciences: in vitro, time-resolved, and 
3D ........................................................................................................................................... 49 
Publication No. 2 (Project): Applying 3D FTIR imaging to CKD investigation ............... 58 
Title: 3D FTIR imaging of the kidney glomeruli’ micro-environment in chronic kidney 
disease .................................................................................................................................. 60 
Publication No. 3 (Participation): ........................................................................................... 79 
Title: Very small photoluminescent gold nanoparticles for multimodality biomedical 
imaging .................................................................................................................................. 80 
Publication No. 4 (Participation) ............................................................................................ 90 
Title: FTIR spectro-imaging of collagen scaffold formation during glioma tumor 
development ......................................................................................................................... 91 
Discussion ................................................................................................................................... 102 
Conclusions & Perspectives .................................................................................................... 106 
Project of International Associated Laboratory – VascView .................................................... 108 
ITEA3.1 European Project – 3Dpathology ....................................................................... 110 
ITEA3.2 European Project – DrugsInOrgans ................................................................... 112 
Reference ................................................................................................................................... 114 
9 
 
 
List of Figures 
 
Figure 1. Schematic overview of the anatomy of a kidney. .................................. 15 
Figure 2. Conceptual framework for the progression of kidney injury.. .............. 16 
Figure 3: Kidney function on body homeostasis.................................................... 18 
Figure 4. Cross-section of a glomerulus. ................................................................ 21 
Figure 5. Micrographs of micro-CT images in vasculature imaging. .................. 27 
Figure 6. Micrograph of a 2D projection of 3D MR image of a human kidney 
injected with labelling image agent for the visualization of glomeruli .......... 28 
Figure 7. Ultrasonography of the kidney ................................................................. 29 
Figure 8. H&E stained micrographs of renal tissue ............................................... 31 
Figure 9. Micrograph of fluorescent microangiography of a glomerulus in 
kidney .................................................................................................................... 32 
Figure 10. The reconstructed micrograph of a dissected region of casted 
kidney by Nano-CT .............................................................................................. 33 
Figure 11. The reconstructed micrograph of a casted glomerulus by Nano-CT
 ................................................................................................................................ 33 
Figure 12. Electromagnetic spectrum of wavelength and frequency and it bio-
applications ........................................................................................................... 36 
Figure 13. The typical biological spectrum on the spectral interval of 3000 cm-1 
to 800 cm-1. ........................................................................................................... 37 
Figure 14. The schematic layout of FTIR spectro-microscopy ............................ 38 
Figure 15. The 2D mapping of the individual formalin-fixed or air-dried cells by 
micro-FTIR ............................................................................................................ 39 
Figure 16. Phase contrast microradiographs of healthy and pathological 
kidneys. ................................................................................................................. 41 
Figure 17. Example of biochemical, molecular and structural parameters found 
discriminant between healthy (top) and pathological (bottom) mice kidney 
samples by FTIR imaging. ................................................................................. 41 
10 
 
Figure 18. The variation of biochemical content in the kidney of UUO mice. ... 68 
Figure 19. Statistical pattern of lipid to protein ratio in renal specimens of UUO 
mice ....................................................................................................................... 70 
Figure 20. The unsaturation level of fatty acid chains molecules in kidney of 
UUO mice. ............................................................................................................ 72 
Figure 21. Average infrared spectra from renal specimens treated with or 
without BaSO4 perfusion. ................................................................................... 74 
Figure 22. The variation of glomeruli volume in kidney due to UUO .................. 75 
Figure 23. Spectral feature on the F.A.C. region in UUO mice clusters. ........... 76 
Figure 24. Stereological variation of spectral feature of glomeruli in UUO mice.
 ................................................................................................................................ 77 
Figure 25. 3D imaging of morphological structure and spectral feature on 
glomeruli in mice after 4-day UUO and normal mice. .................................... 78 
 
  
11 
 
List of Tables 
 
Table 1. The stages of chronic kidney disease based on the estimated GFR 
value ...................................................................................................................... 19 
Table 2. Renal biomarkers involved with pathological progress .......................... 24 
Table 3. Overview of imaging system performed on renal studies. .................... 26 
Table 4. Imaging options in chronic kidney disease. ............................................. 35 
 
  
12 
 
List of Abbreviations 
  
ADMD Asymmetric dimethylarginine 
FAC Fatty acyl chain 
AFM Atomic-force microscopy 
AGE Advanced glycation end product 
ANF Atrial natriuretic factor 
ANP Atrial natriuretic peptide 
AOPP Advanced oxidation protein products 
ApoA-IV Apolipoprotein A-IV 
ATR Attenuated total reflectance 
BaSO4 Barium Sulphate 
BNP Brain natriuretic peptide 
CaF2 Calcium fluoride 
CKD Chronic kidney disease 
CFA Correspondence factor analysis 
CRP C-reactive protein 
CT Computed tomography 
cTnT Cardiac troponin T 
CVD Cardiovascular disease 
ECM Extracellular matrix 
ESRD End-stage renal disease 
FGF Fibroblast growth factor 
FPA Focal plane array 
FTIR Fourier transforms infrared spectroscopy 
Gd Gadolinium 
GFR Glomerular filtration rate 
GGT γ-glutamyltransferase 
H&E Hematoxyline and eosin 
hs-CRP High-sensitivity-CRP 
IL-8 Interleukin-8 
13 
 
KIM-1 Kidney injury molecule-1 
L-FABP Liver-type fatty acid-binding protein 
LN-MRI Lymphotropic nanoparticle enhanced magnetic 
resonance imaging 
MDA Malondialdehyde 
MRI Magnetic resonance imaging 
MSCT Multislice computed tomography 
NAG N-acetyl-β-o-glucosaminidase 
NGAL Neutrophil gelatinase-associated lipocalin 
NT-proBNP N-terminal brain natriuretic peptide 
 
OCLs Quantum-cascade lasers 
OCT Optical coherence tomography imaging 
Ox-LDL Oxidized low-density lipoproteins 
PCA Principle component analysis 
PET Positron emission tomography 
PLS Partial least square 
PTX3 Pentraxin 3 
SEM Scanning electronic microscopy 
sTNFrii Soluble tumor necrosis factor receptor II 
TAS Total antioxidant status 
TBARs Thiobarbituric acid reactive substances 
TGF-β1 Transforming growth factor-β1 
TIMP-1 Tissue inhibitor of metalloproteinases-1 
OCLs Quantum-cascade lasers 
UUO Unilateral ureteral obstruction 
 
14 
 
Introduction 
Chronic kidney disease is a progressive renal dysfunction, which loses renal function over time because of 
direct and indirect factors. Such as physical obstruction, microorganism infection and thickening renal 
tubules are the main direct factors; for indirect factors, the increased blood pressure, anemia and poor 
nutritional supply, mainly attributed to the complication are led by hypertension and diabetes mostly. FTIR 
imaging technique has been proposed to be a useful tool to characterize the chemical change of 
biosamples with pathological conditions. To define the histopathological changes of the kidney with CKD 
by 3D chemical FTIR imaging is helpful to investigate the molecular information of CKD tissue, especially 
focusing on the study of the renal unit, glomerulus.  
In the present study, the imaging methodology of 3D FTIR imaging provides access to the chemical 
parameters of mapped tissue specimens of interest. By using several computational algorithm applied on 
the obtained spectral dataset of renal sample, the samples with different severity of CKD can be 
discriminated with the evaluation of lipid-to protein ratio, unsaturation level of F.A.C.s sub-molecules and 
barium sulfate, reflected to the morphometric change of glomerulus level. 
The tasks of this thesis project is as the following: 
1) To characterize the chemical change of renal tissue of CKD based on the spectral data obtained by 
FTIR soectramicroscopy 
2) To image the compositional information of pathological renal samples for histopathological purpose by 
FTIR imaging 
3) To discriminate the biochemical parameters of glomerulus level between pathological, its contralateral 
kidneys of a mouse with CKD and healthy kidneys with traditional and advanced algorithm applied on 
Spectral data 
4) To discriminate the pathological severity of the kidneys during the CKD progression with multivariate 
data treatment of FTIR 2D dataset 
5) To visualize the spatial distribution of chemical/molecular change of glomerulus level for characterizing 
the histopathological parameters attributed to CKD development. 
 
CKD prevalence 
Chronic kidney disease (CKD) becomes one of the major worldwide public health problems, due to its 
increasing number of afflicted patients as well as the poor prognosis of morbidity and mortality [1, 2]. In the 
United States, the prevalence of end-stage renal disease (ESRD) progressing from CKD is increasing 
exponentially [3]. The number of patients enrolled in the ESRD Medicare-funded program has increased 
from ~ 10,000 in 1973 to 615,899 in 2011. Patients with ESRD consume a disproportionate share of 
healthcare resources. In the USA, the total cost of the ESRD program reached $49.3 billion in 2011 [2, 3] 
and overall annual Medicare costs more than $75,000 per person, including expensive cares such as 
$32,922 for transplant patients and $87,945 for hemodialysis therapy. Despite the magnitude of resources 
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committed to the treatment of ESRD and the substantial improvements in the quality of dialysis therapy, 
patients continue to experience significant mortality, morbidity and reduced quality of life. The same trend 
was observed in Europe and certain developed countries in Asia, such as Japan [4].  
 
CKD is particularly serious in Taiwan, where the incidence of ESRD is now the highest in the world. The 
prevalence of CKD increased from 1.99% in 1996 to 9.83% in 2003. The overall incidence rate during 1997 
to 2003 was 1.35/100 person-years. However, the awareness of CKD is low in contrast to its high prevalence 
in society which increase the difficulty in earlier diagnosis.[5, 6]. The factors compounded with other 
increasing risk of developing CKD, include older age, diabetes, hypertension, hyperlipidemia, and the 
female sex [7, 8] , making this progressive disease an even more serious public health issue in Taiwan. 
 
General information about the kidney 
The kidney is a complex organ that is composed of a variety of different cellular structures. Its internal 
anatomy contains three main sections inward: the cortex, the medulla and the pelvis (Figure 1A) [9]. The 
blood carrying cellular wastes is filtered by renal units called “nephrons” (Figure 1B), located in the cortex, 
removing water-soluble entities into the urine. This blood filtering process takes place in the glomerulus, the 
microvasculature of the nephron, through mediating the surface charge of the glomerular basement 
membrane (GBM) and the pore size in the membrane of the glomerulus barrier [10].  
 
 
Figure 1. Schematic overview of the anatomy of a kidney. (A) Coronal section of the kidney; (B) schematic diagram of a nephron 
[9]. The nephron is the functional unit of the kidney. The glomerulus and convoluted tubules are located in the kidney cortex, while 
collecting ducts are located in the pyramids of the medulla. 
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The renal filtering efficiency of the glomerulus declines when it is subjected to stress from different origins 
or pathological conditions of the organs, which consequently could cause renal failure and further lead to 
the loss of kidney functions (Figure 2) [10]. 
 
 
Figure 2. Conceptual framework for the progression of kidney injury. The risk factors for kidney damage (blue), stages of 
progression of kidney disease (green) and the complications and death (purple). Thick horizontal arrowheads represent the transition 
between the progression of kidney disorder and the outcomes to death. Dashed arrowheads represent the remission of kidney disorder 
which has less frequency than the progression. Solid black arrow lines represent the complications of kidney injury, which includes 
nephron disorder and cardiovascular disease. CVD, for example. Glomerular filtration rate (GFR) reduces as the kidney disease 
progresses, while kidney damage increases in severity [11].  
 
The kidney pathologies often induce secondary pathologies in the body due to the accumulation of toxic 
entities that have not been properly filtered to be removed by urine [12].  The very complex anatomy-
function correlation from macroscopic (organ) to microscopic (glomerulus) levels increases dramatically the 
difficulty in analyze the kidney pathology. 
 
The kidney’s function and body homeostasis 
The kidney has several physiological functions that mediate the interactions of organs within the body, 
including endocrine secretion, metabolic activities (with glycogen storage for ex.) and the regulation of blood 
pressure; however, its primary role is the elimination of waste products. There are two ways the kidney 
controls the homeostasis of the body system: The first is by being the activator through proper functioning, 
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thus supporting systematic balance. The other is by being the target, receiving signals from other organ 
systems to activate downstream reactions. Consequently, the quality of kidney functions are strongly 
affected by a variety of disorders, including metabolic syndromes (diabetes, hypertension and obesity), 
immune-mediated injuries, dysregulation of hormone secretions (impaired balance of erythropoiesis), an 
impaired respiratory system (lung infiltration) as well as pathological conditions originating from the kidney 
itself (ex. glomerulonephritis, nephrosclerosis and polycystic kidney disease) [11]. The complications and 
disorders brought about by renal injury may further contribute to the progression of kidney damage: for 
example, cardiovascular disease (CVD)-induced chronic kidney disease [13]. On the other hand, the 
presence of renal disease usually initiates secondary diseases or worsens the progression of existing acute 
or chronic pathologies in patients. Some examples are given below (Figure 3). 
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Figure 3: Kidney function on body homeostasis. The interactions between the kidney and other organ systems are mediated 
properly in order to maintain the systemic balance of body. FGF= fibroblast growth factor. ANF= atrial natriuretic factor [11] 
 
The result from the wide interactions existing between the kidney and other organs is that many pathologies 
can affect the body’ homeostasis, and thus make the appreciation of the physiological function of the kidney 
difficult. It is obviously more complex once a pathology occurs, either in the kidney to affect other organs, or 
from these organs to affect the kidney functions. 
 
Defining chronic kidney disease 
When a disease affects the kidney progressive renal injury can occur, and will later be followed by renal 
inefficiency and an impaired filtering function; this pathological development is referred to as ‘chronic kidney 
disease’ (CKD) [1, 14]. It is difficult to detect the early symptoms of CKD before the situation of the patient 
presents comorbid disorders [15]. During the progression of CKD, the disorders induce functional and 
anatomical alternations in the organ, which both interactively contribute to the complexity of CKD. The 
decrease in kidney function in CKD is primarily caused by the loss of functional nephrons, the basic units of 
blood filtration and cleaning [16]. The efficiency of glomerular filtrating activity is tied to the reduced amount 
of working nephrons, and has thus become a standard of estimating the level of kidney injury in CKD. In 
2002, the National Kidney Foundation (NKF) gave a clinical guideline that proposes the definition of CKD 
based on the level of GFR, and created the classification of 5 stages to characterize the development of 
CKD (Table 1) [17-19]. In this report, CKD is characterized by a decrease in GFR to a level below 60 ml/min 
per 1.73 m2 of average body surface area for at least three months’ time, or a significant increase of 
biochemical markers in the urine (ex. albuminuria) of the patient. The latter is based on the structural injury 
of the glomerular membrane barrier, in which the permeability to macromolecules is altered, allowing for the 
appearance of proteinuria in the CKD patient. 
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Table 1. The stages of chronic kidney disease based on the estimated GFR value [19]. 
 
Renal failure in CKD 
Numerous studies have confirmed as well as discussed the pathophysiological characteristics and the 
progression of CKD in human and established animal models [20-22]. The common features include 
appearance of fibrotic tissue, increased oxidative stress, inflammatory infiltration and cellular shape 
aberrations, which collectively contribute to the pathogenesis and progression of CKD [23]. Biomolecules - 
including DNA, protein, lipid, and carbohydrates - are usually subject to oxidative stress, and their alteration 
leads to dysfunction in cellular functions. Renal fibrosis is the most significant clinical outcome of a severe 
CKD, and it appears at the end-stage of renal function [24]. Renal fibrosis occurs progressively in either 
renal interstitium or glomeruli, and alters the renal parenchyma by forming scar tissue, which is mainly 
composed of collagens [25, 26]. The destruction of normal kidney parenchyma’ tissue due to proliferated 
fibrotic components leads to a distorted function and structure of glomeruli, renal tubular and also causes 
microvasculature reductions, all resulting in the decrease of glomerular function. It finally results in the 
retention of fluids in renal tissue, as well as a hypoxic condition that is induced by impaired oxygen supply 
from scarred blood vessels [27]. However, the level of pathophysiological features in CKD does not only 
correlate with the estimated GFR in CKD patients [28]. Existing research indicates that increased oxidative 
stress and inflammation are observed to be prevalent in patients with CKD earlier in the course of kidney 
disease than previously recognized by the estimate of GFR, and these observations would not be closely 
correlated with estimates of GFR. Hence, there is a need to use a reliable methodology with sensitivity and 
quantitative value for determining the level of each biochemical parameter useful for staging the kidney 
injury in CKD, which will be especially important in the early detection of disease symptoms [29].  
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Glomerular patho-physiology 
During the progression of CKD in human and animal models, the glomerulus is the most susceptible sub-
structure of renal tissue [30]. Capillary-loop glomerulus, with its selective permeability to blood circulation, 
is the central functional part of nephrons in the kidney. The segmented renal tubule which collects filtered 
fluid from glomerular capillary is followed by the reabsorption of water and small molecules back to body 
(Figure 4). Blood filtration takes place in the glomerular part of the capillary tube, selectively transferring 
water-soluble molecules (urea, glucose, various salts, amino acids, and mineral ions) across the glomerular 
barrier but retaining high molecular weight plasma components and cells, like albumin and erythrocytes, 
forming the primary urinary fluid. The portals on glomerular barriers are a cluster of windows with diameters 
between 60-100 nm, which restrict the cross-traffic of blood-filtrated solutes with the selectivity in size and 
surface charge. Besides the glomerular capillary, the glomerular vasculature consists of afferent arteriole 
and efferent arteriole, which serve as the entrance and exit for blood flow in glomerulus, respectively. The 
ongoing afferent arteriole is of larger diameter than the outgoing efferent arteriole, which mediates 
glomerular blood pressure as a control system in regulation of GFR [31]. Each kidney holds approximately 
900,000 to 1,000,000 nephrons in an adult human [32], depending on age, size, race, gender as well as 
birth weight [33]. A lower nephron number is considered as a risk factor in CKD, and the overloading of renal 
filtration in the remaining working nephrons is often a consequence, which further worsens the glomerular 
injury, and is followed by a loss of more working nephrons [20]. Thus pathologies in the kidney are mostly 
degenerative or evolutive. 
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Figure 4. Cross-section of a glomerulus. The glomerulus is a tuft of capillaries located within Bowman's capsule of the kidney. Blood 
enters the capillaries of the glomerulus by an arteriole called afferent arteriole and leaves by an efferent arteriole. The capillaries are 
lined by a layer of endothelium cells that has a unique structure, allowing blood components to be filtered and resulting ultimately in 
the formation of urine (http://www.fmc-renalpharma.com/the_kidneys.htm). 
 
Degenerative glomerular efficiency 
Numerous renal disorders involve glomerular injury, which can be unspecific histopathological features of 
proliferated scars, thickened glomerular membrane, macrophage infiltration and cell proliferation in the renal 
parenchyma [34]. Most evaluating methods rely on histological or fluorescent staining on prepared tissue 
specimen. The pathogenesis of glomerular lesions refers to the fibrotic scarred or hyaline-deposited 
glomerular vasculature in glomerulosclerosis (ref). The inflammation of the glomerulus refers to 
glomerulonephritis, characterized with hyper-cellularity. Under the conditions of injury, the thickening of the 
impaired Bowman’s capsule membrane causes the decreased diameter of the vascular pole of glomeruli, 
or the urinary pole of Bowman’s capsule. The glomerular function impairment thus represents the outcomes 
of the filtration inefficiency, proteinuria, and uremia.  
 
The activated signal pathway responding to increased oxidative stress, inflammation and fibrosis in renal 
degeneration promotes the renal functional deterioration that triggers abnormal cell growth, cellular death 
of necrosis and apoptosis as well as alternates the selective binding capability or permeability of regulator 
protein in mediating cellular processes. Abnormality of fibroblast growth may occur in the renal tubule, 
glomeruli and the renal artery or veins, which in turn affect the reabsorption and blood circulation within the 
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kidney, reducing glomerular efficiency. The transformed cellular shape may exhibit a different structure due 
to increased oxidative stress, causing abnormal tissue architecture. A report from the study of urinary 
obstruction-induced renal damage has indicated elevated levels of oxidative stress and a diminished amount 
of anti-oxidant catalases within the kidney. On the other hand, increasing oxidative stress and inflammation 
in turn promotes the progression of renal dysfunction. 
 
In histopathology, glomerular lesions have several categories based on the patterns of glomerular injury, 
either in geometry or in origin site, such as the extent of injured glomeruli in the kidney (focal or diffused), 
the pathological level of injured glomeruli (segmental or global) and whether the lesion originated from 
glomeruli, or was spread into glomeruli (glomerulonephritis or glomerulopathy). The geometric pattern of 
glomerular injury is thus much reliant on the examination of morphological change on a large amount of 
individual glomeruli in the kidney, to differentiate the glomerular pathology.  
 
Glomerular importance in CKD 
Most research studies the level of kidney injury through the examination of molecular change, via genetic 
and cellular experiments in biopsies and structure alternation. This is done through optical microscopic 
imaging in 2-dimensions (2 D). Histopathological approaches to evaluate renal pathology have performed 
well in clinical trials and medical studies by providing contrast between signal visualization evidence with 
staining, and preliminary quantitation of renal specimens. A variety of highly specialized types of cells are in 
charge of maintaining renal homeostasis in the kidney, and the structural change as well as the functional 
variation of these types of cells are tightly integrated to generate the net extent of kidney function. However, 
the structural complexity of glomeruli and its associated glomerular filtration remains the barrier for the 
incomplete conclusion of glomerular injury, which is strongly correlated with renal function in traditional 
approaches. The score of renal tubule lesions and interstitial injuries examined in the histopathological 
results represent the limited correlation with glomerular conditions.  
 
The reports show that the glomerular volume in the kidney represents an indicator of glomerular injury, as 
the glomerular disorder does not exhibit symptoms in the histopathological level at the beginning of renal 
impairment. The change of size, shape, and microstructure of glomeruli thus makes a great contribution to 
the examination of glomerular injury, especially in some glomerular diseases. Therefore, reaching a more 
accurate reflection of renal function via scoring the glomerular injury comes down to the requirements of 
morphometric information of glomeruli provided by imaging approaches. In facilitating the exploration of 
glomerular architecture within visualization artwork, the task of reconstructing the full 3D characteristics of 
anatomic and functional alternations is turning to be the key target of current bioimaging methodologies. 
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Justification of GFR and other markers of the kidney in clinical and experiment 
studies 
As the increasing prevalence of CKD has been observed in the developed countries of the world, the new 
pathological methodology for detecting CKD in its early stages as well as its severity is becoming an 
important issue concerned by nephrologists. Current histological protocols used widely in clinics are usually 
assigning GFR tests and urine assays for proteinuria [35, 36]. In the evaluation of CKD severity, GFR value 
is the most common indicator of renal function, but not tightly related to the early structure alternations in 
the kidney which would identify the subtle damage [37]. Many aspects of physiological factors about 
glomerular, tubular, and interstitial tissue can contribute to the occurrence of proteinuria, and the significant 
structure damage of renal tissue usually appears before the proteinuria is measureable [38]. The GFR 
estimation for diagnosing renal function typically measures the variance of the many molecules involved 
with the system disorder, which are usually associated with renal function. Several molecular studies also 
contributed to the finding of potential biomarkers related to kidney disease with some desirable properties 
[39]. Table 2 lists the molecules that have been discussed for the involvement with renal disorders [40]. The 
category of biomarkers listed is on the basis of pathological mechanism. 
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  Biomarker 
Kidney function (GFR) Cystatin C 
  β-Trace protein 
Tubulointerstitial injury NGAL 
  KIM-1 
  NAG 
  L-FABP 
Glomerular injury Podocin 
  Nephrin 
  Podocalyxin 
Endothelial dysfunction ADMA 
Oxidative stress Ox-LDL 
  AOPP 
  TBARS 
  Plasma and urinary F2-isoprostanes 
  MDA 
  Protein reduced thiols 
  TAS 
  Protein carbonyls 
  AGE 
  Urinary 8-hydroxydeoxy guanosine 
  4-hydroxy-nonenal 
  Antioxidant enzyme activities (e.g., superoxide dismutase, glutathione peroxidase, catalase) 
  GGT 
Inflammation CRP and hs-CRP 
  PTX3 
  sTNFrii 
  IL-18 
  Tenascin 
  TIMP-1 
Fibrosis TGF-β1 
Cardiovascular dysfunction ANP 
  BNP and NT-proBNP 
  cTnT 
  Adrenomedullin 
Metabolic disorders Adiponectin 
  FGF-23 
  ApoA-IV 
  
Table 2. Renal biomarkers involved with pathological progress [40]. Abbreviations: ADMA, asymmetric dimethylarginine; AGE, 
advanced glycation end product; ANP, atrial natriuretic peptide; AOPP, advanced oxidation protein products; ApoA-IV, apolipoprotein 
A-IV; BNP, brain natriuretic peptide; CRP, C-reactive protein; cTnT, cardiac troponin T; FGF-23, fibroblast growth factor-23; GFR, 
glomerular filtration rate; GGT, γ-glutamyltransferase; hs-CRP, high-sensitivity-CRP; IL-18, interleukin-18; KIM-1, kidney injury 
molecule-1; L-FABP, liver-type fatty acid-binding protein; MDA, malondialdehyde; NAG, N-acetyl-β-o-glucosaminidase; NGAL, 
neutrophil gelatinase-associated lipocalin; NT-proBNP, N-terminal brain natriuretic peptide; Ox-LDL, oxidized low-density lipoproteins; 
PTX3, pentraxin 3; sTNFrii, soluble tumor necrosis factor receptor II; TAS, total antioxidant status; TBARS, thiobarbituric acid reactive 
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substances; TGF-β1, transforming growth factor-β1; TIMP-1, tissue inhibitor of metalloproteinases-1. 
 
The clearance rate of endogenous plasma substrates in blood and urine 
Analyzing body matrices like blood and urinary biopsies in order to evaluate the amount of plasma 
substances provides a flexible and easy access point to quantify the variations of global renal function from 
the two kidneys of patients. Several biomolecular clearances rates such as creatine and insulin are 
evaluated within 24 hours, with the standard method for estimating GFR serving as the estimation indicator 
when considering acceptable applications in hospitals for most patients, as well as the preliminary assay in 
laboratory studies. However, the goal of pursuing more accurate analysis representing detailed information 
of the renal function still remains. The poorer quantitative measurement of determining GFR value 
represented by standard equation is attributed to the heterogeneity of race, sex, and the nature of the 
individuals as well as age of the patient. The other issues in performing standard biopsy methods include 
the time-consuming nature of analysis procedures, the limited availability in obtaining biopsies of some 
patients as well as emerging cases of the patient. 
 
Bioimaging approaches for CKD 
Different imaging modalities provide a way to monitor the complexity, diversity and the distribution of 
systematic disorders of the patients on the respect of morphology and function (Figure 7) [41]. Methods 
such as X-ray CT [42], magnetic resonance imaging (MRI) [9, 43], positron emission tomography (PET) [44], 
optical microscopic imaging (confocal fluorescent imaging, two-photon imaging [45], optical coherence 
tomography imaging (OCT) [46]), ultrasonography [47] and scanning electron microscopic (SEM) imaging 
are applied to visualize the renal parenchyma in the examination of glomeruli, renal tubules, renal 
arteries/veins and other renal tissue. Table 3 illustrates a comparison of the imaging techniques, performed 
on the kidney. The advantage of these imaging modalities is the ability to provide detailed structural and 
functional information on tissues and organs. The noninvasive characteristics of some imaging techniques 
exhibits the capability of visualizing full 3D reconstructions of renal vasculature, with or without additive 
imaging agents depending on imaging instruments. 
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Figure 7. Imaging techniques used in biomedical research. Many macroscopic imaging technologies (shown above the timeline) 
are in routine clinical use, and there have been huge advances in their capabilities to obtain anatomical and physiological information 
since the beginning of the twentieth century. Shown here are some examples of bones (X-rays), soft tissue (ultrasound, MRI and CT 
rows), 3D organs (CT and MRI rows) and physiological imaging (MRI and PET rows) [41]. MSCT= Multislice computed tomography. 
LN-MRI= Lymphotropic nanoparticle enhanced magnetic resonance imaging. 
 
Technique Resolution Time Depth Multi 
channel 
Imaging agent 
used 
Clinical use Reference 
X-ray CT 50 µm Minutes No limit No Iodinated molecules, 
Barium particles, 
Carbon dioxide 
Yes [42, 48] 
MRI 10-100 µm Minutes to 
hours 
No limit No Magnetic chelates, 
Magnetic particles 
Yes [9, 43] 
Ultrasound 50 µm Seconds 
to minutes 
cm No Microbubbles Yes [49] 
PET 1-2 mm Minutes to 
hours 
No limit No 18F-, 64Cu- , 68Ga- or 
11C-labelled 
compounds 
Yes [44] 
Multiphoton 
fluorescenc
e imaging 
1 µm Seconds 
to minutes 
200 µm Yes Photoproteins, 
Fluorochromes 
No [45] 
Intravital 
microscopy 
1 µm Seconds 
to minutes 
< 1 cm Yes Photoproteins, 
Fluorochromes 
Not yet [50] 
OCT 5-10 µm Seconds 
to minutes 
1-2 mm No No need Not yet [46] 
Table 3. Overview of imaging system performed on renal studies. 
 
 
X-ray computer tomography 
CT, equipped with an X-ray light source, is an imaging tool that has the high penetration capabilities to 
create 3D reconstruction visualizations of imaged subjects in clinical and medical research [51-54]. The 
interior structure of a sample examined by X-ray CT is globally extracted to differentiate the anatomic 
features of soft tissue and hard tissue (ex. bone skeleton) via phase-contrast signal, due to the difference 
of refractive index between cellular components of tissues [55]. For example, in bone imaging, X-ray 
micro-CT is used as an accurate tool to precisely measure changes in bone stereology, volume and micro-
architecture. Thanks to the 3D information extracted from biosamples while using micro-CT imaging, CT 
provides a feasible access to quickly and effectively assess phenotypic parameters of soft tissue [56].  
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Vascular imaging in small animal is also made possible by either injecting blood contrast agents for in vivo 
imaging microvascular anatomy (Figure 5), or by in vitro casting vasculature with silicon-based 
compounds [57, 58]. 3D volumetric imaging of microvasculature within the organ or the tumor allows for 
statistical examinations of the physical parameters within blood vessels in a quantitative manner, as well 
as the ability to observe the 3D architecture of vascular system while the organ remains intact. Hence, X-
ray micro CT technology provides a means to explore the microvascular network, even with disease 
conditions in development. 
 
 
Figure 5. Micrographs of micro-CT images in vasculature imaging. (A) A micro-CT projection through a clinical CT image of the 
intact rat. A mammary fat pad tumor of 1.5 cm was developed in this animal. The visualization of microvascular network in the brain 
(B-D) and kidney (E-G), and abnormal vessels within the tumor (H-J) [59]. (B, E and H) are the projections of multiplanar reformatted 
images. (A, C, F and I) are the maximum intensity projections. (D, G and J) are the projections of volume rendering. Scale bar is 0.5 
cm. 
 
Magnetic resonance imaging based morphometric analysis of glomeruli in whole kidney 
Recent renal studies using MRI imaging techniques show significant achievements in the examination of 
glomerular morphology and functional information [60-62]. Highly biocompatible MRI contrast agents are 
perfused into vasculature for in situ and in vivo bioimaging, followed by the quick elimination of contrast 
agents in 24 hours; which makes the later observations with other experiments workable without destruction 
damage [63-65]. The advantage of MRI imaging is that it holds the capability of creating a 3D quantitative 
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visualization of glomeruli, via labeling with MRI contrast agents against GBM in small animal models and 
human kidneys [62, 66]. 
 
 
Figure 6. Micrograph of a 2D projection of 3D MR image of a human kidney injected with labelling image agent for the 
visualization of glomeruli. The MR image exhibited dark spots throughout the renal cortex of the agent-labeled kidneys. Each dark 
spot in the cortex is ∼50–80% darker than the surrounding cortex [43]. Field of view = 6 × 10.5 cm3 
 
Quantification of glomeruli in normal or diseased kidneys entails the examination of glomerular size, the 
total number and the pattern of distribution in a whole kidney of a dog, a rat and a human, respectively, 
based on in situ measurement of MRI data. This includes each glomerulus in kidney, and not the estimation 
used in stereology performed in histology [43, 62, 67]. Though there is a difference in afore mentioned 
information between MRI and stereology [68], it is important to note that the bias of estimation or 
measurement in different methodologies, and the heterogeneous nature of each kidney from the individuals 
[69]. The perfusion efficiency and leaking level of the MRI contrast agent within glomeruli is further examined 
to describe the histopathological change of correlation with glomerular morphology in some reports [61]. 
Architecture disorders of glomerular capillary, epithelial podocytes and glomerular basement membrane 
somehow contribute to protein leakage, reflecting on MRI image data by the distribution of the imaging 
contrast agent in the examined kidney. 
 
Image processing and statistical analysis of the MRI signal should be preprocessed to eliminate noise 
inference and set a proper threshold for digital data computing, which may need supporting information 
acquired by other methodologies. The reports also indicated the concern of separating MRI signal changes 
from the blood- or the MRI contrast agent- artifacts that reduce false signals of glomeruli. The reconstructive 
digital data based on nondestructive sample preparation represents quantitative analysis in micrometer 
resolution, and takes significantly shorter time than that of the stereological method. 
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Renal ultrasonography morphology 
Ultrasound (US) imaging in clinical use as well as medical studies has been frequently used to 
visualize the interior structure of many organs, and also to monitor the stage of disease 
progression in small animal models and human [70]. The advantages of US imaging is that it is an 
inexpensive and noninvasive imaging modality that can be used in clinical diagnosis. Renal 
ultrasonography is a feasible modality in diagnosis and prognosis for evaluating renal size, renal 
mass, and symmetry (shape) of the kidney in the patients (Figure 7) [47, 71, 72]. Another 
advantage of ultrasonography for bioimaging is the usage of contrast agents such as microbubbles 
to compensate for the limitation of low sensitivity in small blood vessels (< 2 mm in diameter), and 
provide an access point to perform serial examinations of the patient’s target disease [73]. Using 
contrast agents in ultrasonography prevents the interference from any movement of examined 
objectives, which may cause artifacts recorded in the data [74]. 
 
 
Figure 7. Ultrasonography of the kidney. (A) normal kidney, (B) enlarged and echogenic kidney with loss of differentiation between 
cortical, medullary and sinus fat compartments in a case with acute kidney injury, (C) small, slightly echogenic kidney with thin cortex 
in a patient with chronic kidney disease and (D) normal size but echogenic kidney with a single simple cyst in a patient with chronic 
kidney disease secondary to diabetic nephropathy. [47] 
 
High blood flow in the kidneys make US imaging quite suitable to be applied in the examination of renal 
vasculature. The morphological information of the whole renal vascularity, including the renal artery, sub-
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capillary as well as renal hemorrhage can be revealed by the enhanced-Doppler signals of US imaging, and 
provides a fast and easy way to identify of vascular disorders and lesions in the kidney [49]. The global 
quantification work of renal vasculature is possible to reach in 3D US imaging with contrast agent-enhanced 
US imaging [75, 76]. The accessibility of US imaging coupled with physical microbubbles in clinical use has 
been why it has been proposed to study kidney impairment, but the renal function should be taken into 
concern, and not without regard to patient’s renal condition. However, lower resolutions, sensitivity and 
specificity of US imaging either in laboratory work or clinical use remain the barriers of fine examination in 
kidney studies. No report of US imaging shows the glomerular anatomy and function, though there are some 
studies that claim the supplementary role in diagnosing glomerular disease [77]. Exposure to mechanical 
ultrasound in the kidney can cause capillary hemorrhage of nephrons, leading to the consequence of 
nephron injury, observed in some reports [78, 79]. 
 
Microscopy techniques in histology 
Hematoxylin and Eosin (H&E) staining as a basic tool for histopathology 
Using the H&E method to stain biosamples is the most common method, routinely used in histology to 
identify cellular components of tissue, and also to distinguish tissue morphology. The advantage of the H&E 
method in histopathology is to provide a well-acceptable standard by well-trained pathologists for 
determining the presence of disease, disease grading and the measurement of disease progression. As of 
recently, there are proposals of using automated computational methods in detecting and segmenting image 
datasets to perform the histological identification of shapes and topology on a series of 2D images, to be 
used in reconstructed image work [80, 81]. 
 
With the counterstaining of the nucleus in purple, and the eosinpholic structure in a different grade of red 
with chemical dyes, the classification of cellular components and the identification of the anatomic features 
of the tissue is aimed towards discriminating the markers for the pathological state, on the basis of the 
relevant analysis through light microscopy. Figure 8 exhibits the architecture of glomeruli and the renal 
tubules of the healthy kidney, and a pathological kidney damaged by the uptaking of mercuric chloride 
(HgCl2), examined by histopathological H&E staining [82].  
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Figure 8. H&E stained micrographs of renal tissue. (A) Normal glomerulus (G), parietal layer of Bowman's capsule (arrows) and 
urinary spaces (s) in a control rat. Note: normal proximal convoluted tubules (P) and distal convoluted tubule (D) (H + E; 400×). (B) 
Interstitial exudate (short arrows), shrunken glomerulus (G) with fluid exudate (long arrows) filling the urinary spaces. Note: Cytoplasmic 
vacuolation (V); pyknotic nucleus (p) with intra-luminal cast formation (arrowhead) of the tubular epithelium in a rat fed with HgCl2 [82]. 
Fold= 400X 
 
 
Fluorescent imaging of glomeruli for functional study  
Through usage of fluorescent probing in the various molecules participating in structural organization and 
physiological processes, the mechanism and morphology involved can be examined with quantitation and 
visualization. Very specific labeling, with fluorescent probes directly against the molecules provides a 
reliable indication for representing the inherent information of biological samples. Thanks to the innovations 
of optical and physical developments in imaging modality, multiphoton image data is collected in sharp, high 
resolution, and with deep optical imaging capabilities greater than ten micrometers, which is the limited 
thickness for confocal laser imaging. When applied to in vivo animal imaging, the optical depth of imaging 
is demonstrated to be up to 150 μm below the surface, while imaging dissected thick specimens is around 
1 mm via optical dissecting in z-axis with optimized focal depth step. To our understanding, multiparametric 
analysis of physiology and anatomy in biopsies offers a practical way to build 3D visualization of physiology 
in glomeruli via various labeling markers imaged by multiphoton microscopy. As another way, a simple 
fluorescent imaging without specific recognition can be performed to represent a glomerular structure by 
injecting fluorescent material into blood vasculature system (Figure 9) [83]. 
 
32 
 
 
Figure 9. Micrograph of fluorescent microangiography of a glomerulus in kidney. The kidney was perfused with the mixture of 
agarose and fluorescent microspheres before imaged by confocal fluorescent microscopy. The image represents of a 3D reconstructed 
projection of a glomerulus [83]. Scale bar = 100 m 
 
 
Alternative method: Morphological visualization of glomerular vasculature by corrosion 
casting-based investigation 
Corrosion casting methods coupled with optical microscopic instruments have been used to study the 
microvascular architecture of biosamples such as tumor tissue, the brain, liver and kidney [84-88]. By 
perfusing resin particles that preserve the shape of blood vessels within the biosamples, the morphological 
variation of vasculature related to pathological states is stereologically examined to verify the grading of the 
disease, and locate the distorted vascular position. The reconstructed imaging of blood vessel networks of 
the casted biosamples is established by a variety of imaging modalities, such as SEM and X-ray microscopy 
[87, 89]. Recent studies indicate that the corrosion casting method, coupled with ultrahigh resolution Nano-
CT X-ray microscopy, have shown improved imaging quality, with sub-micron resolution in the 3D geometric 
visualization of renal microvasculature (Figure 10) and glomerular capillary loop(Figure 11) [90].  
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Figure 10. The reconstructed micrograph of a dissected region of casted kidney by Nano-CT. The capillaries of the glomeruli 
were resolved (large arrow) as well as peritubular capillaries (small arrow) which were irregular in shape and surrounded blank spaces 
normally are occupied by the proximal and distal tubules of the kidney [90]. Voxel resolution is 0.77 m. 
 
 
Figure 11. The reconstructed micrograph of a casted glomerulus by Nano-CT. Branched capillaries were clearly resolved (Left). 
The model was also available to view the interior of a glomerulus (Right) [90]. Voxel resolution is 0.5 m. 
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Clinical imaging techniques for evaluating renal function in CKD 
Medical imaging with proper tracing compounds are considered to be helpful in identifying the causes of 
CKD, as well as being able to characterize the features of CKD patients (Table 4) [91]. The method of 
measuring the kinetic curve of gadolinium (Gd) chelates contrast agent by MRI is used to trace glomeruli in 
certain studies [92, 93]. The time-density signals of contrast tracers by MRI could be useful for the estimation 
of functional imaging, with the statistical analysis of quantification of perfusion, quantification of glomerular 
filtration rate, estimation of tubular function. These measurements could parameterize renal function and/or 
renal morphology while using such contrast agents injected into kidney. With real-time 3D visualization of 
kidney morphometry, it is possible to access the activity of a single kidney on the basis of intrarenal tracer 
kinetics and differentiation between the global GFR of each kidney within patients. The examination of an 
MRI agent’s clearance in a specific kidney may feasibly allow for a more accurate diagnosis of renal disease, 
for both clinical management and reference information. 
 
Similar to kinetic MRI measurement, another imaging option used to estimate the GFR value in a single 
kidney is the X-ray tomography, with a contrast agent for monitoring dynamic glomerular function based on 
tissue and vasculature density kinetics. The Renal Mass Index gathered by CT scanning acts as a potential 
indicator of GFR value, which exhibits high correlation with the measurement through clearance of 
iopromide. Absolute quantitative measurement of the concentration of a CT contrast agent in a perfused 
kidney allows for real time monitoring in GFR over time, as well as providing the anatomic information 
through angiography. 
 
The potential limitation of imaging modalities in estimating GFR is the injection of contrast agents into the 
patients in clinics. Allegory response and nephrotoxicity induced by injected contrast agents may result in 
negative effects of renal disorder, especially those with poor renal efficiency.  
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Table 4. Imaging options in chronic kidney disease. 
 
 
Emerging technique: Infrared spectral imaging in biochemical analysis 
General information of IR spectromicroscopy 
Electromagnetic waves of infrared (IR) radiation span between the red end of the visible light, to the starting 
end of microwaves (780 nm to 1000 μm wavenumber), and is composed of three parts, recognized as near-
IR, far-IR and mid-IR, respectively (Figure 12). For IR spectral investigation in biological specimens, the 
most commonly useful region is the mid-IR region between the wavelength 2.5 μm to 25 μm, corresponding 
to the frequency region in the unit of reciprocal centimeters, from 4000 cm-1 to 400 cm-1. In the mid-IR region, 
the IR vibrational spectrum observed on biosamples contain many unique features of organic contents, 
which absorb a specific frequency of mid-IR radiation to enter the resonant state. The energy absorbed by 
intra- or inter- molecular bonds generates the periodic motion, resulting in a net charge in the dipole of 
electron density between the atoms of chemical groups within molecules, which is in turn related to atomic 
masses and the strength of chemical bonds. Therefore, this spectral variation is useful in the differentiation 
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of disease disorders through the analyzing of collected IR spectra signals. The advantage of Fourier 
transform (FT) IR spectrometers, coupled with microscopy for biomedical studies are thus becoming an 
analysis method with reproducible measurements on the sample, with spatial analytical capabilities of 
biochemical components of specimens, free-labeling from tracers in samples, and most importantly, the 
ability to acquire structural or functional signals of the biological components in their natural state. 
 
 
Figure 12. Electromagnetic spectrum of wavelength and frequency and it bio-applications. Here is a classical electromagnetic 
spectrum aligned with its common and established biomedical imaging application. IR region is located between visible and microwave 
regions with indication of red arrow [94]. 
 
FTIR spectral information in biological samples 
The vibrational models of the molecular family of the biosamples can be quantitatively measured by mid-
FTIR spectroscopy. For biological specimens, the most useful spectral regions are 1200-900 cm-1 for 
carbohydrates, 1700-1480 cm-1 for protein and 3050-2800 cm-1 for lipids (Figure 13) [95, 96]. The recorded 
wavenumber of specific molecules families of biosamples are quietly constant but the overlapping of the 
absorptions between different molecular families is observed because various molecules existed within the 
biosamples. Proteins mainly contribute to the absorption on Amide I region which peak is basically around 
1650 cm-1 (the most vibrational mode is C=O stretching plus C–N stretching and N–H bending) and Amide 
II region which peak is basically around 1540 cm-1 (N–H bending and C–N stretching). Lipids majorly 
contribute their absorptions to several interval regions such as one is for C-H stretching vibrations on the 
37 
 
interval of 3050-2800 cm-1; another is for C=O stretching vibration peaked around 1740 cm-1. The absorption 
of glycogen is majorly around 1030 cm-1. The PO-2 stretching vibrations attributed from nucleic acids are 
peaked around 1080 cm-1 for symmetric vibration referring to s (PO2-) and around 1225 cm-1 for asymmetric 
vibration referring to as (PO2-) [97]. Position and intensity of the absorption spectra (or bands) are 
determined by the molecular and/or conformational structure (ex. -helix, -sheet, -turn and random coils 
of protein secondary structure [98]) of these components within the biosamples. These unique fingerprints 
of absorption spectra are useful to identify biochemical compositions of the biosamples and provide the 
information about the nature, the content, and microenvironment of the bio-components [99]. 
 
  
Figure 13. The typical biological spectrum on the spectral interval of 3000 cm-1 to 800 cm-1. Major biochemical components of 
biosamples are assigned in their proper position on the spectrum.  for stretching vibration;  for bending vibration; s for symmetric 
vibration; as for asymmetric vibration [95]. 
 
FTIR imaging system 
Modern FTIR spectro-microscopy has three major components: the IR light source, the interferometer and 
the detector to couple with the computer, in order to save the large data acquisitions composed of the whole 
of spectral information (Figure 14). A thermal light source such as a tungsten carbide Glowbar is a 
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convenient bench-top source of IR, providing continuous polychromatic IR radiation, which generates a wide 
range of frequencies spanning broad bands from 500 to 4000 cm-1. A monochromic laser IR source focuses 
on a narrow range or a single frequency. Other available choices for IR light source are quantum-cascade 
lasers (QCLs) [100, 101] and synchrotron X-rays [102, 103] with the benefit of improved imaging quality 
[104]. For the imaging purposes of IR instruments, a detector with multi-channels arrays and a focal panel 
array (FPA) is equipped to perform microscopy for the faster collection of data, with over 4096 (64x64) pixels 
and more with each data acquisition [105]. These types of IR sensitive detectors are composed of a large 
number of small detectors arranged on a grid-like pattern, similar to the mapping system. For a sample 
model using IR spectromicroscopy, transmission, reflection and attenuated total reflection (ATR) are 
generally available for the users depending on the experiment requirements and sample characteristics. 
 
 
Figure 14. The schematic layout of FTIR spectro-microscopy. The instrumentation of this FTIR modality represents the general 
purposes, which includes transmission and the reflection model of sample configurations (only the transmissions model is shown in 
the layout), dual detectors for point mapping and imaging mapping, external interference and computer for data acquisition and 
processing [106] . 
 
During the data acquisition of pixel spectra obtained from each grid point of a setting pattern by IR spectro-
microscopy, equipped with a FPA detector, the individual spectral pixel renders the images corresponding 
to each wavenumber of a selected region. This presents a spectral work in term of FTIR imaging, which 
combines the spectral multiplexing and multichannel detection of optical microscopy (Figure 15) [107]. For 
bioscience, FTIR imaging on biosamples provides a resolved information pool specifically supported by the 
chemical characteristics examined from the spectra of complex tissue or cells [108, 109]. 
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Figure 15. The 2D mapping of the individual formalin-fixed or air-dried cells by micro-FTIR. The FTIR images of the cells are 
plotted by representing the integration of spectral intervals from a series of spectra, collected point by point scanning a selected area 
[107]. For the spectral range of 3000-2800 cm-1, the plot represents of the lipid intensity by the ratio of CH3 to CH2 groups in lipids; for 
the interval between 1690 cm-1 and 1640 cm-1, the protein content is represented by the integration of amide I and amide II region.  
 
Biomedical application of FTIR imaging 
Since several decades ago, IR spectroscopic technique has been extensively used as an analytical tool in 
biological studies, the usage includes biofluids and complex tissue. In a few early studies, non-imaging IR 
works on the differentiation of tumor markers and the DNA features of cell lines. Xenografted tumor cells 
and tumor tissues gave examples of identifying pathological state [110, 111]. The development of 
microscopy allows this IR technique to not only be an alternative optical platform for histopathology in the 
laboratory, but also a promising technique in clinics [112, 113]. FTIR imaging modality is becoming able to 
routinely and rapidly provide high-quality data for experiment use, as well as be easily accessible to users 
[114]. 
 
Thanks to the technique innovations for IR modality, the improvements such as better sensitivity and 
spatially resolved information for chemical characterization of the biosamples as well as high throughput 
data recording makes this imaging approach be receiving an address for diagnostic and prognostic 
purposes. FTIR image data provides the morphological and biochemical information of the biosamples, 
which was thought to be useful in clinics. IR measurement on biofluids is also an ideal approach with the 
advancement of fast and non-invasive sample collection potential biomarkers for clinical purposes [115]. By 
using such methods, spectral fingerprint data of biofluids is available for histological classification by 
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computational data treatment [116, 117]. 
 
The art of 3D FTIR imaging technique on histopathology 
Histopathological methods for classifying FT-IR imaging data have been developed only recently [118, 119]. 
The algorithm is aimed towards acquiring high confidence levels by using a large amount of tissue samples. 
The optimal set of data metrics was incorporated with an algorithm with diagnostic potential. Then, this 
model is applied on the FT-IR image data treatment. Spectral and spatial information extracted from each 
data point of the FTIR image dataset are used to determine the presence of the disease and its severity. In 
traditional histological methods, supervised classification is performed on the chemically stained data, 
followed by classification by an expert pathologist for setting the gold standard. The combination of 
classifying the FT-IR imaging data coupling, added with H&E stained visible image data is believed to 
provide further improvements in tissue segmentation. For the first step, the image data is aligned and 
overlaid sequentially. This can be done by using a smoothing filter to identify rough shapes and/or 
morphological features. Segmentation and feature extraction algorithms then process the combined data 
sets. This method can thus yield highly accurate classification results on the basis of morphological and 
chemical information in 3D. 
 
Why combine X-Ray tomography and FTIR imaging for CKD analysis? 
The study of CKD animal models by X-Ray tomography has reached an unprecedented level of performance 
at the Nano-X Laboratory in Taipei. Using intense X-Ray beams (synchrotron radiation), a 3D analysis of 
glomeruli distribution in kidneys has become feasible in 3D (Figure 16). However, the glomerulus cannot be 
characterized with the respect of GFR and their micro-environment. Combining a chemical microscopy 
technique with high-resolution X-ray tomography imaging has thus received attention, and its prospects at 
being able to complete the 4D information consisting of 3D morphology, and spectral characteristics at the 
glomerulus level of the kidney are also promising. 
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Figure 16. Phase contrast 
microradiographs of healthy and 
pathological kidneys. 
 
 
The number of glomeruli is obviously higher in healthy kidney (left) and accompanied by a denser microvasculature in the cortex 
than observed on the pathological specimen (right) - (unpublished data – Academia Sinica). 
 
Our preliminary work by using FTIR imaging has shown the result of a structural, metabolic, molecular 
parameter on renal specimens (Figure 17), although it was limited to 2D analyses and at the single 
glomerulus level. We obtained preliminary evidence that several biochemical differences could be 
highlighted by FTIR microscopy between a healthy kidney and one that is pathological. 
 
 
Figure 17. Example of biochemical, molecular and structural parameters found discriminant between healthy (top) and 
pathological (bottom) mice kidney samples by FTIR imaging. Diabetic nephropathy model in db/db mice. Left to right: Visible 
image (10 µm-thickness, 171x171 µm area with a glomerulus); Full IR absorbance image (FSA: 3900-900 cm-1 – scale 200 - 950); 
Oxidative stress level in tissue exhibited by (C=C-H)/as(-CH3) absorption ratio (scale 0 - 2.6); glucose distribution (1033 cm
-1 band – 
scale 0 - 0.35); glycogen distribution (1025 cm-1 band– scale 0 - 0.65); lactic-acid distribution (1127 cm-1 band– scale 0 - 1.1) 
collagens distribution (1637 cm-1 band– scale 0 - 0.35). 
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Objectives 
Current pathological methodologies used in laboratories and hospitals remain as insufficient quantitative 
diagnosis, with limited 2D information in renal epidemiology. Most imaging techniques performed in renal 
studies are very reliant on indirect measurement of chemical substrates, injected into or against tissue 
specimens to acquire histopathological information. To date, 3D FITR imaging could be proposed as a 
potential approach to evaluate the multiple parts of chemical/molecular information based on probe‐free 
techniques, in order to provide global information of a sample specimen for histological purposes. 
 
The objective of this PhD thesis project is to use FTIR imaging to investigate the biochemical difference and 
morphological changes of the glomerulus level present in the kidneys of mice with CKD. We use functional 
algorithms of spectral clustering and spectral curve fitting to quantitatively differentiate the variation of the 
spectral features and the content of functional groups (-CH2, -CH3 and -C=CH) in fatty acyl chains (F.A.C.s) 
molecules inherited in renal specimens. The results are based on the 3D measurement of consecutive renal 
biopsies of the mice, with CKD examinations using the practical potential of 3D spectral imaging in the renal 
histopathology with geometrical examination. 
 
In our work, we first studied the difference of lipid and protein content between a pathological kidney and its 
contralateral kidney of mice with CKD, and a healthy kidney of a control mice that has not undergone surgery. 
To distinguish the histopathological change in renal specimens of mice with different levels of CKD, the 
characteristic absorptions of lipid molecules on -CH stretching region and protein Amide I region, 
respectively, is analyzed to discriminate the biochemical change of glomerular region and non-glomerular 
region in renal specimens. Then, based on unpublished work in our laboratory about the estimation of the 
multi-parameter algorithm, we proposed to analyze the 3D geometric variation of molecular content change 
and the globally spectral characteristics in F.A.C.s molecules in glomeruli. The aim of this study is to 
characterize the pathological glomeruli of the kidney at the different level of stress (days 4 to 14 undergoing 
UUO) based on the spectral chemical characteristics.  
 
The last part of the objective in this thesis is to evaluate 3D FTIR imaging in examining 3D glomerular 
morphology with disease progression. In the previous work of the laboratory, we found that filling blood 
capillaries with barium sulfate microparticles was a superb way to mark the microvasculature position in 
tissue organs. Thus, we propose to discriminate the 3D morphological change of glomeruli based on the 
characteristic absorption of barium sulfate injected into the renal blood system. 
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Methodology 
The PhD thesis work is part of a bilateral research program between the Inserm U1029 laboratory in 
Bordeaux and the Nano-X laboratory of Academia Sinica in Taipei. The main aim of this bilateral project is 
to setup a multimodal imaging facility using common contrast agents to merge images from different imaging 
modalities, and the usage of common data treatment methods to ensure a combination of sample 
information obtained from different sources. The two major techniques developed in this context are the X-
Ray and IR microscopies, both for obtaining 3D images of biosamples, from cells to animal models and for 
human biomedical research purposes. In the future, the goal will be to analyze biospies or surgical exereses, 
where the imaging methods will be applicable to provide relevant information about the sample, notably for 
diagnostic purposes. 
This methodology section thus aims at defining how we could proceed in developing animal models suitable 
for multimodal imaging, i.e., applying both X-Ray and IR microscopy techniques, which imaging contrast 
agent could be used for such multimodal image acquisition; and how an infrared microscopy methodology 
has to be developed in order to reconstruct 3D chemical images of the biosamples. 
 
Animal experiments 
In present work, we used the mouse model of CKD, initiated through physical surgery of unilateral ureteral 
obstruction (UUO). Chronic renal injury was induced in B6/C57 male mice by obstructing one ureter for up 
to 14 days. In this work, the UUO model initiated a rapid sequence of events in the obstructed kidney, leading 
to reduced renal blood flow and GFR within 24 hours. At the time points of 4, 9 and 14 days after UUO, the 
obstructed kidney of the mice had varying degrees of hydronephrosis. In the past, one of the advantages of 
the UUO model was the presence of the contralateral kidney as a control sample in the experiment. In the 
present study, the contralateral kidney is considered another experiment group for verifying the renal and/or 
glomerular functions in UUO mouse model. 
 
The experimental mice were euthanized and processed with injection of PBS saline solution to drain out the 
blood. The kidneys were collected immediately after perfusing the animals with a prepared imaging agent 
solution (barium sulfate, BaSO4) and were frozen in liquid nitrogen. Sample preparation for tissue imaging 
was performed by cutting the kidney into sections 10-µm thick using cryostat set at −20 °C. Tissue sections 
were subsequently placed on CaF2 IR-transparent slides and left to be completely dehydrated at room 
temperature. 
 
Imaging contrast agents 
Contrast agents in bioimaging techniques provide a direct visualization of targets of interest. When the 
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imaging technique reach a microscopic resolution, it becomes feasible to trace the functional part of the 
vascular system of an organ or the whole body, limited by the field of view of the technical setup. The digital 
information revealed by an imaging agent in a biosample can be processed with different computing 
algorithms to quantitatively evaluate histopathological features. For example, when using X-ray imaging to 
examine the vasculature of an organ, small-size gold nanoparticles (Au-NPs) can be used to image the 
morphology of individual blood vessels, which are further collectively compared by appropriate statistical 
methods. Another contrast agent, BaSO4, is a good candidate for examining the vasculature of a tissue or 
an organ, but due to the larger dimension of NPs ( ≥ 1 µm), it is not likely that all microvessels can be 
imaged in this way. These imaging contrast agents have not been associated with a significant toxicity in 
live animals after IV injection. Thus, a microscopic view of the vascular system in tissue and organs is 
feasible. It allows for generating quantitative information about the vascular network, such as the density, 
the angles of branching point per volume, the dimension of blood vessels and change in their diameter…etc. 
Our previous publication has shown that using Au-NPs and BaSO4 to image tumor vasculature is efficient 
in discriminating different tumor phenotypes in small animal models by FTIR imaging [120]. 
 
In present studies, the BaSO4 microparticles suspended in the sucrose solution is washed with PBS saline 
solution three times, to replace the sucrose solution with PBS solution before used in vessel perfusion. This 
work of resuspending BaSO4 in a physiological buffer is thought to preserve the physiological balance of 
blood vessel during perfusion treatment.  
 
FTIR imaging  
Data acquisitions 
Consecutive tissue sections were obtained from a mouse kidney to allow the stacking of 2D images and full 
glomeruli reconstructions. After cryosectioning (10-µm thick tissue sections), every tissue section was 
deposited on a CaF2 window (2-mm thick) and analyzed by FTIR imaging, using an Hyperion 3000 spectral 
imaging system equipped with a Vertex 80 spectrometer (Bruker-Optics, France), a liquid-N2 cooled focal 
plane array (64×64 elements 40×40 μm each) detector, and a SuperGlowbar source (18V – 6-mm diameter 
at detector position). A ×15 magnification level and condenser were used for obtaining a final FTIR image, 
with a pixel dimension of 2.6×2.6 μm, thus at ∼λ/2 for the mid-IR spectral interval. All infrared images were 
obtained in transmission mode from the tumor sections in the 4,000–900 cm−1 range by using 500 scans 
with spectral resolution of 4 cm−1. Once the visible image was obtained, the tissue area was selected to 
cover one glomerulus. Typically, the FTIR images were obtained for 2x2 FPA scanning, thus covering a 
171x170 µm tissue area. All data acquisition, post-processing (atmospheric CO2 and baseline corrections), 
and image constructions were performed using rubber band corrections with the 64-points method, by sub-
routines of the Opus 7.5 software (Bruker-Optics, France). 
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Spectral interval absorptions 
Before calculating the spectral absorption parameters, firstly the average spectrum was taken from the FTIR 
image of each obstructed renal tissue. The averaged spectrum of each diseased group was found to be 
almost identical in terms of absorbance values (comparable intensity scale between spectra). After baseline 
correction had been applied on each FTIR image spectra, classification of FTIR spectra of renal tissue was 
performed by using the absorption intensity ratio between the spectral interval of fatty acyl chains (3050-
2800 cm-1) and the Amide I spectral region (1700-1600 cm-1)of proteins, respectively. The lipid-to-protein 
ratio based on intensity integration of these spectral regions is used to differentiate the biochemical changes 
of renal tissue from healthy to diseased animals. Then, the average spectrum of 4096 pixels per FPA from 
each central section of glomerular tissue block was used for further statistical analysis. Thus, the spectral 
alterations between the experimental conditions reflect pathological alterations rather than experimental 
uncertainties. This single 2D FTIR analysis is also performed in the advanced spectral curve fitting process. 
 
For specifying the morphological change of glomerulus within renal tissue, the spectral absorption of 
imaging agent BaSO4 is used as an indicative marker of glomerulus structure, and is verified by its intensity 
domination in the spectral interval of 1220-995 cm-1, which is composed of four main bands discussed in 
our previous result [120]. Before investigating the anatomical information of glomerulus, the dominating 
contribution of BaSO4 is determined by the absorption intensity of the integrated area attributed to four 
spectral intervals. The last main band (1220-1160 cm-1) of BaSO4 is found to show the highest absorption 
intensity compared to the other spectral intervals. Thus, we decided to choose this spectral interval as an 
index to verify the glomerular structure. For evaluating the 3D interior anatomy of the glomerulus, the 
integrated absorption of 1220-1160 cm-1 for BaSO4 is also used to quantitatively measure the pathological 
change caused by the UUO with the benefit of visualization information. 
 
Statistical analyses on spectra 
Hyperspectral data analysis is often viewed as a statistical pattern recognition problem in a three 
dimensional hyperspace, often envisaged as a hyperspectral data cube. These methods usually begin with 
a statistical approach to find image ‘end members’. Statistical methods range from simple hierarchical 
cluster analysis, to complex methods such as minimum noise transforms and the RSI ‘hourglass’ method. 
In contrast to these statistical methods, a more traditional spectroscopic approach can be taken, where the 
analyst concentrates on recognizing absorption band shapes in each individual spectrum. This has the 
advantage of a direct connection between the transmittance spectrum of the target pixel and its chemical 
composition. When the hyperspectral dataset is viewed in this way, classifications are made according to 
underlying physical properties, rather than simply on their similarity to other pixels in the dataset. We decided 
to test both of approaches, classifying spectra for recognizing families of entities having large similarities, 
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but also by developing a curve-fitting method allowing to extract individual bands that could be assigned to 
known chemical entities. 
 
Classical cluster analysis 
The spectral clustering method we used is a multivariate algorithm, which aims to categorize spectra data 
into separate groups according to their characteristics (here the variables are spectral intensities, used 
either at the single wavelength level, the spectral region level or through a combination of either). Clustering 
is performed such that the spectra which are held within a cluster are as similar as possible (homogeneous 
in spectra data profile) while other spectra placed in different clusters are as dissimilar as possible. Therefore, 
different chemical characteristics found within biological tissues can be separated and characterized. In 
present studies, cluster analysis was performed in the range of 3050–2800 cm−1 with the use of 2nd 
derivatives (calculated with the Savitzky–Golay algorithm and a 9-points smoothing level). The number of 
classes range at least from 3 to 12 clusters to verify the appropriate classifying number. After the clustering 
classification, generated clustering images are taken to match with the bright-field image to verify the 
distribution pattern of cluster groups, in order to determine a group which has as much as similarity of the 
glomerulus. 
 
Curve fitting 
The chemical components of biosamples examined by FTIR imaging were studied by a curve fitting 
procedure that individualize bands constitutive of a broader spectral interval. The method we used includes 
the ability to detect small relative shifts in absorption band central wavelength, the ability to separate 
overlapping absorption bands in a stable manner, and relatively low sensitivity to noise [121]. The reader is 
invited to confer to the reference mentioned here for a detailed curve-fitting procedure. I used this curve-
fitting procedure for the extracting absorption band in the 3050-2800 cm-1 spectral interval, although I did 
not participate to the development of this method per se. Here, the =(-CH)/
as
(CH
3
) and the =(-
CH)/
as
(CH
2
) ratio can be used as indicative indexes of fatty acyl chain unsaturation in lipid contents of 
tissues, which is directly linked to oxidative stress. The unsaturated/saturated ratio was calculated by taking 
the ratio of the area of the C=CH olefinic band (3012 cm-1) to that of the C–H2 stretching band (2928 cm-1) 
or to that of the C-H3 stretching band (2975 cm-1) specifically recognized and extracted by the curve fitting 
process on all spectra of 2D images. 
 
47 
 
3D FTIR image reconstructions 
After the data treatment of three kinds of analysis methods mentioned above on the raw FTIR image data, 
the generated FTIR spectral image with its characteristic spectral information is used in 3D stacking 
procedures for plotting 3D visualization. Before performing 3D stacking work, an alignment work is carried 
out to precisely position the two adjacent images of consecutive FTIR image data in their X, Y and tilt 
positions. However, realignment procedures can sometimes be impossible due to tissue deformation (at the 
sample sectioning step, where tissue deposition on substrate can lead to irreversible tissue shape 
modifications). It has made the number of finalized results in this PhD work quite limited, and thus did not 
allow for large statistical studies on a cohort of samples. To align the adjacent FTIR images of consecutive 
tissue sections, feature tracking based on the morphological detail in every tissue section is performed to 
complete the 3D alignment work. Because of the tissue deformation generated during the sample 
preparation, the morphological features within the tissue used for the alignment lies on the similarity shared 
between two adjacent sections. The final step of stacking 3D FTIR imaging is to merge all aligned 2D FTIR 
images with corrected voxel size in the X, Y and Z axis. A 3D video was finally obtained by producing a 
sequence of 3D stacked images, aligned properly with the use of Amira software. The rotating axis of a 
video, either with one of the three axes or in the coordinates of any position, is dependent on the best view 
of the point of interest within the reconstructed objective. The aligned frame of 2D images is rendered to a 
10-second movie composed of 250 frames at the final phase of generating the 3D movie. 
 
For verifying functional change of the glomerulus in a kidney, we use barium sulfate intensity in the spectral 
interval of 1160-1220 cm-1 to mark the vessel position pixel by pixel for generating a full view of the 
glomerular ball. The position parameters based on barium sulfate absorption is used, in order to load into 
the alignment process on the 3D image stacking of cluster analysis. Thus, a functional change and the 
chemical characteristics of a glomerulus is examined with 3D information. Moreover, the information of 3D 
FTIR imaging is completed by merging two datasets of 3D stacking images, using the information generated 
from a set of raw image data. 
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Results 
In this PhD work, we proposed a spectral image based approach for analyzing biochemical issues, 
specifically the change of the glomerulus level of a kidney with CKD by multivariate analysis. Functional 
studies with 3D volumetric imaging on biosamples should be conducted into the pathological aspects of a 
disease study, after X-ray based imaging techniques provide remarkably clear and informative images in 
anatomy of the biosamples. To allow for quantitative and visual advantages on biological studies, an imaging 
agent based on nano-size gold particles was developed with multi-optical characteristics for X-ray, 
luminescence and possible IR imaging. Its chemical characteristics of biocompatibility, and its large 
internalization by tissue cells are suitable for its use of multimodal bioimaging. In the core study of this thesis, 
the 3D glomerular microvasculature is examined by using barium sulfate microparticles injected into blood 
vessels to reveal the morphology of the vasculature network of individual glomeruli within the kidney, which 
have different levels in severity of CKD (day 4 to day 14). The statistical results gleaned from the successive 
sections of a glomerular tissue block showed the lipid peroxidation and the ratio variation of lipid and protein 
molecules which exist between healthy and pathological kidneys, all completed by FTIR spectral imaging. 
With the chemical characterization based on the spectral data by 3D FTIR imaging, the grade of CKD in the 
small animal model can be determined based on the molecular components of the glomerulus unit within 
the kidney.   
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Publication No. 1: 
 
Title: the future of infrared spectroscopy in biosciences: in vitro, time-resolved, and 3D 
 
In this paper, we propose the new potential developments of IR imaging technique, including: 1. the analysis 
requirements of IR bioimaging for its current performance and; 2. the improvements of 2D IR imaging to 3D 
IR volumetric visualization; 3. to push its application to real-time cellular measurements. FTIR spectroscopy 
has been used as an analytical tool, used to study the chemical information of examined samples for 
decades. The development of microscopy, which can be equipped with IR spectroscopy and the utilization 
of an array-based IR detectors, help IR imaging in becoming an imaging technique that is a convenient tool 
for histological studies. The advances of FTIR imaging are majorly attributed to its simpler sample 
preparation, faster measurement of biosamples compared to other imaging technique, and highly feasible 
access to quantitative analysis due to spectral metrics of IR data, acquired through IR instruments. However, 
IR imaging techniques have limitations on lower spatial/lateral resolutions of image data, lower sensitivity 
for tracking the element/molecules within biosamples, and temporal resolution so it cannot compete with 
other imaging technique in the analysis of biochemical change on biosamples, nor the structure information 
of small molecules. Other challenges for FTIR imaging in biosciences include the long-term demand for 
different levels of biological compositions, from sub-molecules, cells, tissue… to satisfy the multimodal 
requirement by researchers. Such cellular experiments in IR imaging have been performed with the data 
acquisition of ATR to obtain even real time record of the cells. As of recently, the development of IR 
instruments with improved physical properties on optical devices has been proposed, to allow for better 
performance in IR data collection and data quality. This will contribute to the accomplishments of 3D 
measurement in an efficient way. 
 
In biological studies, the application of FTIR imaging has been maintained in 2D scale measurement for a 
long time because demanding high throughput of data metrics in 3D has to face many passes to reach 
feasible and reliable accomplishments in biosciences. The utilization of a high-energy light source, such as 
a laser source, was considered as one of the reliable choices for increasing the strength of IR imaging 
technique on bioscience by overcoming the diffraction limit of Glowbar IR light, as well as shortening the 
time requirement for 3D bulk data acquisition. Thanks to the high-energy source used in IR modality which 
upgraded its capability to obtain data measurement with improved quality, its applications in measuring 
cellular level or 3D tissue blocks by IR spectroscopy becomes more practical, because of better S/N quality, 
enhanced sensitivity for the sub-cellular molecules and rare elements as well as more reliable spectral data 
of successive tissue specimens. For live IR imaging, cellular samples requires stricter experiment setup to 
maintain its conditions as same as its culturing state. 
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Infrared (IR) spectroscopy is at the cross-roads, with the requirement to compete with cutting-edge technologies 
in biosciences, mostly based on analytical performances dealing with the super-resolutions: time, lateral/spatial, and 
contrast. IR microscopy is diffraction limited in most cases, thus not accessing to high lateral/spatial resolutions. 
Additionally, it has a poor signal-to-noise ratio on a single scan, thus requiring long-lasting acquisitions that are not 
suitable to analyze ns-lasting biochemical events. However, it is unique because it provides a broad global chemical 
information of the sample contents. It is also unique because it does not require heavy sample preparation nor labeling 
and can be coupled to other techniques (multimodality). Finally, it is again unique because it provides quantitative 
measurements, thus suitable for 1D to 4D data exploitation procedures. This short review shows that IR spectroscopy 
will be certainly subjected to a second century of innovations, maintaining its influence in the panorama of cutting-edge 
analytical techniques. 
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1. Introduction 
FTIR spectroscopy has been developed more 
than a century ago for analytical chemistry 
purposes, in 1893 in its principle by Nichols [122] 
and popularized a bit later by William Coblentz 
[123]. The purpose was to develop the first 
spectra database of molecules and to release 
tables of wavelengths at which various materials 
absorb IR light. For almost half a century [124], 
FTIR spectroscopy has remained a unique 
analytical resource to probe the structure of small 
molecules, but its influence in chemistry has been 
minored by the development of other techniques, 
notably  Nuclear Magnetic Resonance (NMR) 
and crystallography. After a century of 
instrumentation development, the main use of this 
technique has moved from molecular analyses 
towards the understanding of complex biological 
systems [125]. In the 90’s, FTIR spectroscopy 
instrumentation focused on other applications 
with the release of spectrometers able to collect 
spectra on sample holders dedicated to 
quantitative, thus reproducible and comparable, 
measurements. The study of biofluids [126-128] 
has first shown that triplicate  
＊ corresponding author ; e-mail: cyril.petibois@u-bordeaux.fr 
measurements  
 
allowed to obtain high reproducibility in spectra 
acquisitions with no more than 1% of change in 
absorptions on average[129, 130]. Another major 
advance in FTIR instrumentation for biological 
applications has been the development of the 
microscopes, as while their principle was 
established as early as 1949 [131], their ability to 
be used with both visible and IR modes [11] was 
found useful for bioscience. FTIR imaging 
systems have the advantage of a quite fast 
spectra acquisition since the microscope is 
coupled to an array of IR detectors, which may be 
linear (16 or 32 detectors) or focal plane (64*64 
or128*128 detectors) [96]. At this state of 
technological development, FTIR imaging was 
considered as cutting–edge technology for 
biosciences since the reduction of time for spectra 
acquisitions [132] allowed applications to large 
tissue areas and thus opened IR to the medical 
field [114]. The use of high-intensity (or high-
photon flux) sources could be also considered as 
a major advantage to obtain high S/R levels with 
shorter acquisition durations [133-136]. Cell 
imaging applications were also demonstrated 
taking into account a few analytical requirements 
to fit analytical standards in biology [133, 135, 
137-139]. However, in the current competition for 
proposing high-performance analytical means for 
biosciences, it seems that FTIR instrumentations 
suffer from a major lack of R&D efforts, and 
traditional manufacturers have not released major 
innovations for almost 20 years. It results that the 
most obvious advantages of FTIR spectroscopy 
and microscopy for biosciences – a global 
chemical characterization of unaltered samples 
without labeling – are now completely outreached 
by many other techniques, notably those based 
on shorter wavelengths (UV to X-Ray range). In 
this context, several key challenges must be 
considered by the IR spectroscopy community to 
open new avenues for IR applications in 
biosciences. This review tackles the main R&D 
efforts to consent for achieving this objective. 
 
2. Analytical requirements for bioimaging by 
IR spectroscopy 
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Molecular bio-imaging has imposed a new way to 
analyze cells and tissues (figure 1). From 
vibrational spectroscopies (mainly infrared, and 
Raman) to particle-based techniques (using 
energy of X-rays, -rays…), a wide range of 
microscopy techniques now fit some of the 
analytical features required for biological 
investigations [140]. The first feature is about the 
spatial resolution, which is determined by the 
physical principle of the technique[141]. In the 
electromagnetic spectrum, the wave-matter 
interactions can be exploited to reveal biosample 
features within the nm to cm range. The nm 
dimension refers to molecules, the fundamental 
bricks of living systems, and the cm range refers 
to the functional units (tissue structures) of these 
ones (figure 1). Because they are complex and 
structured systems, cells and tissues require to 
obtain data only at the micrometric scale or better 
for morphological analysis (anatomic imaging, 
from cytoskeleton in cells to multicellular 
assemblies in tissues). Major techniques exist for 
sub-micron analysis of cells and their sub-
compartments [138]. The place of IR microscopy 
is interesting in this panorama of analytical 
techniques as it allows analyzing some of the 
most fundamental structures of biological 
specimens, i.e. at micron-scale dimensions, thus 
at the sub-cellular, cell, and sub-tissue levels. 
This is a range of dimensions that is currently 
poorly covered by existing microscopy techniques, 
which are either resolving super-resolution 
features on small volumes (or limited field-of-
view), or do not provide sufficient lateral/spatial 
resolutions on larger specimens (mm3 or bigger). 
IR microscopy has the advantage of a quite low 
diffraction limit (typically 
  
Figure 1: Analytical techniques allowing a 
microscopic analysis of biosamples, from nanometer to 
millimeter dimensions and for different biological 
targets. 
 
~3-20 µm for the 4000-500 cm-1 mid-IR interval), 
but also a weak penetration depth (5-30 µm for 
soft materials like tissues), thus limiting its 
applications in biosciences. 
Another feature to consider in biological imaging 
is the temporal resolution, which will determine 
the applications of techniques for time-resolved 
analyses. This temporal resolution for biological 
applications is also related to sample stability 
during data acquisitions [142]. The physical 
properties of imaging modalities will determine 
their applicability on time-resolved analyses in 
biology. Most of imaging modalities using 
accelerator-based sources are not designed for 
analyzing living specimens due to the utilization of 
high energy beams. However, molecular 
dynamics may be determined out of the living 
environment, such as for the analysis of proteins 
folding or conformation under stress conditions 
(pH, temperature, etc.), where high energy may 
be required for time-resolved data acquisitions 
within the ms-ns range of time [143]. 
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The third main feature to consider for determining 
the applicability of imaging modalities to the 
biological field is the sensitivity. In this domain, it 
is clear that accelerator-based sources play their 
most significant role for enhancing analytical 
performances, namely by increasing the S/N level. 
This allows one to perform data acquisitions 
closer to the diffraction limit or to reduce the time 
of acquisition for obtaining information on kinetics 
of biological samples, the so-called time-resolved 
experiments. In this sense, IR microscopy has not 
been considered as a valuable technique for 
biological dynamics. The major developments of 
IR instrumentation to biological applications so far 
have been focused on sub-diffraction live cell 
imaging [134, 136, 139] and high-throughput 2D 
tissue analyses [96, 112, 137, 140]. Therefore, in 
the battle for achieving the best compromise 
between sensitivity, resolution, and time of 
acquisition, IR microscopy remains limited by the 
low-photon flux of its conventional IR sources 
(Glowbar) and the diffraction limit. 
 
3. From FTIR to IR spectroscopy and 
microscopy… the road to 3D 
In principle, FTIR microscopy is too slow in 
spectra acquisitions and provides too weak S/N 
levels to allow comparison between large spectra 
data sets, i.e. millions to billions of spectra. The 
S/N being dependent on environmental factors as 
well as electrical noise from the analytical 
instrumentation, there is little chance to obtain 
highly reproducible spectra for long-lasting 
acquisitions. This limit is affecting biological 
applications in the sense that quantitative 
changes in many chemical contents distribution 
(in cells or tissues) will remain very limited for 
physiological reasons. The example of glucose 
concentration in a normal physiological condition 
is a good demonstrator of what the biological 
variability is: blood concentration is normally 
ranging between 0.8 and 1.3 g/L and remain very 
close to 1 g/L in most of the cellular and 
extracellular compartments. Therefore, one may 
not expect major changes in glucose 
concentration distribution in tissues, and 
analyzing this molecular parameter at the 
microscopic spatial resolution will require 
accurate quantitative method with low margin of 
error in measurements, at least not superior to 2-
5 % of average value. FTIR spectroscopy and 
microscopy have not demonstrated that level of 
accuracy on triplicate measurements in biofluids 
[129, 130], and thus one may not expect obtaining 
such analytical performance on successive tissue 
sections analysis. This slow acquisition issue 
must be overcome to expect developing FTIR 
microscopy for 3D applications. Although IR 
microscopy is not suitable for direct tomographic 
measurements on biosamples – because: 1- IR 
photons have limited depth of penetration in 
matter [96, 133], 2- biosamples contain >60% of 
water with unmanageable absorptions [139], and 
3- transmission measurements do not allow 
resolving absorptions in a true confocal geometry 
[136] – its quantitative nature should allow the 
reconstruction of a 3D matrix of spectra. 
The recent release of microscopes powered by 
IR-laser sources is allowing new approaches for 
biological applications, with the opportunity to 
obtain high S/N spectra in short time, probably 2 
or 3 orders of magnitude faster than with the 
Glowbar sources. The wavelength-by-wavelength 
signal acquisition do not require the use of the 
Fourier transformation for spectra reconstruction 
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(thus reducing mathematical approximations in 
absorption calculations), and provides absolute 
count of photons on detector, thus ensuring more 
accurate quantitative analysis of biosamples. 
These microscopes are not yet exempt from limits. 
They use several quantum-cascade lasers to 
cover a large spectral region (1700-900 cm-1 is 
currently proposed), which poses the question of 
the signal intensity reliability and continuity 
between lasers. This is a fundamental question to 
consider quantitative analyses of chemical 
contents in 3D tissue blocks. Anyway, with a fast 
and high S/N level spectra acquisitions, IR 
microscopy should allow reconstructing a large 
3D matrix of IR spectra for tissue analyses (see 
proposed method in figure 2). The main purpose 
might be to introduce a new concept of spectral 
data treatments and exploitation, named 
‘spectromics’ [144], which is essentially the use of 
any spectral information (or combination or 
calculation of data extracted from spectra) that 
allows discrimination of two objects (ex. healthy 
vs. pathological tissue or sub-structures inside the 
same tissue volume). Different spectral data 
treatment methods have been developed so far to 
extract an individual (ex. an IR band) or a well-
identified (ex. amide I region) chemical 
information from spectra. 
  
Figure 2: Developing 3D IR microscopy for tissue block 
analysis. The concept of 3D digital histology can be 
developed by IR microscopy due to its intrinsic 
advantages, i.e., a global chemical analysis of 
biosample contents, a quantitative access to these 
ones, and a suitable sampling methodology for 
unlimited chemical data treatments of raw matter. The 
proposed methodology includes an automated tissue 
sectioning for obtaining reliable 2D images (visible and 
IR) that can be further stacked for 3D block 
reconstruction. Spectral data treatments are further 
performed for reconstructing 3D chemical information 
distribution with quantitative value in the tissue. 
 
The 3D reconstruction of these data might provide 
unique information about a tissue, with 3D 
resolved sub-structures correlated to biochemical 
or metabolic events. This would lead to the 
combination of morphological and molecular data 
into the same 3D image of a biosample, thus 
comparable to the MRI/CT or PET/CT multimodal 
imaging methods, but with three major 
advantages: 1- a single technique would be used 
(thus using a single dataset of IR data), 2- 3D 
reconstruction will be performed at the 
microscopic scale (down to /2, i.e., a 3-µm 
spatial resolution is achievable), and 3- without 
the use of any label or imaging contrast agent, 
thus avoiding sample manipulations and 
alterations. 
 
4. From dry to wet biosampling in IR 
microscopy, and down to nanoscopy 
Recently, it has been proposed to use the 
attenuated total reflectance (ATR) acquisition 
method to obtain live cell images without 
constrain of the diffraction limit [139]. With 
synchrotron radiation source, this imaging can be 
performed in short time, i.e., in less than one 
minute, thus allowing to characterize 
macromolecular sub-cellular contents change 
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[134]. Again, benefiting from the above mentioned 
innovations for high-speed and quantitative 
analyses, IR microscopy might become the first 
analytical technique able to determine metabolic 
and biochemical change in cells in vitro, thus 
opening the way to pharmacological 
experimentations on dose-response effects of 
drugs at the single cell level [138, 145]. In fact, live 
cell imaging might concentrate all the benefits 
from technological innovations found in the new 
line of IR microscopes, with time-resolved, highly 
  
Figure 3: Principle of time-resolved in vitro IR 
spectroscopy, with high-speed and nanometric 
analyses. Nano-IR analyses are feasible with 3D 
rendering from AFM measurements. The example here 
shows a sketch for protein-receptor (VEGF/VEGFR) 
interaction analysis by both non-contact liquid AFM and 
ATR-IR microscopies in a coordinated mode. A ms-
range spectral acquisition is possible with analysis of 
conformational change of protein-receptor interaction 
by IR spectroscopy using the amide I&II spectral 
interval (1700-1500 cm-1) and with polarized beam for 
magnifying the amideI/amideII absorption changes.   
sensitive and quantitative measurement below 
the diffraction limit (down to λ/400 as IR-laser 
sources are coherent, thus not limited by 
diffraction, which is reinforced by the use of ATR  
 
devices that are collecting the evanescent wave 
on surface of the reflecting substrate),all features 
collectively inaccessible for any other microscopy 
technique, except maybe for Raman, but this one 
will be less sensitive and more resolutive than the 
IR microscopy. This might open again the debate 
between these two vibrational spectroscopy 
techniques for high-end microscopy applications 
in biosciences, to the delight of spectroscopists! 
The in vitro applications with ATR devices have 
been also developed for the measurement of 
nano-scaled biosamples [146], namely proteins or 
sub-cellular species, such as chromosomes of 
polymerized biomolecules [147]. The coupling to 
an atomic-force microscope (AFM) is 
fundamental as it allows a 3D rendering that can 
be coupled to the co-localized acquisition of IR 
spectra, thus providing a volumetric and 
quantitative analysis of nano-sized biosamples 
(figure 3); down to pixels of ten nm only [148]. This 
innovation should allow the development of 
fundamental experiments that are currently not 
possible with X-Ray free electron lasers (X-FEL) 
or other super-resolution analytical techniques, 
namely the real-time nanoscopy in structural 
biology [149]. The example shown in figure 3 is 
showing possible application for in vitro analysis 
of membrane protein (a receptor) interaction with 
a ligand (here a growth factor), which can be 
performed with biochemical/metabolic cascade of 
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event if a microfluidic device is developed for that 
purpose. 
 
5. Conclusion 
IR spectroscopy offers significant analytical 
advantages over most of the other techniques in 
the field with a quantitative and global chemical 
rendering of a biosample. The recent 
methodological efforts allowing to perform in vitro 
analyses for single cell imaging and data 
treatments methods for extracting given chemical 
data from spectra, among other examples, show 
the relevance of the development of a new line of 
microscopes, much faster, sensitive and 
resolutive than the first generation. Laser-
powered IR microscopes are arriving and promise 
analytical performances that should facilitate the 
development of time-resolved (in the ms range) 
and 3D (for tissues) applications with 
incomparable outputs. The strength of IR-lasers 
is also making that nano-resolved species can be 
analyzed at λ/400, thus approaching the single 
molecule level with quantitative and volumetric 
rendering thanks to the coupling of an AFM. This 
should reintroduce the IR microscopy and 
nanoscopy into the panel of cutting-edge 
technologies for enhancing our knowledge on 
biosamples, from single molecule, to single cell 
and to tissues (even organs in small animal 
models), as well as in routine analyses for 
biomedical and biological research purposes. 
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Publication No. 2 (Project): Applying 3D FTIR imaging to CKD investigation 
This paper represents the core study of the PhD work, with the development of a methodology for 
characterizing biochemical and functional changes in glomeruli in the development of the CKD pathology 
within small animal models. The animal models were prepared at TSGH in Taipei (supervision: Prof. 
Ann Chen and Dr. Shuk-Man Ka), the analyses by X-Ray tomography were performed by the Nano-X 
laboratory in Taipei (supervision: Prof. Yeukuang Hwu), and the analyses by FTIR imaging were 
performed at the Inserm U1029 LAMC laboratory in Bordeaux (supervision: Dr. Cyril Petibois). The aim 
of this international integrated project is to explore a new methodology involving 3D multimodal imaging 
techniques for diagnosis analysis; specifically, progressive renal disease. The merging of X-ray/IR 
imaging techniques to investigate the pathological features of CKD has the advantages of characterizing 
3D anatomical information of the kidney, and allowing for global examination of biochemical contents of 
the renal tissue blocks. This is a systematic approach of combining morphology and function study to 
study a disease progress at the organ level. 
 
The deficiency of the glomerulus level in the kidney is a heterogeneously progress of losing renal 
function, and the level of filtering efficiency in individual glomerulus units vary region by region in a 
kidney organ. The changes and occurrences of renal pathological causes on the obstructed kidney make 
the diagnosis and prognoses of obstruction induced CKD (UUO animal model) inaccurate, and thus 
faces the difficultly of tracing disease development. We propose to use the FTIR imaging strategy to 
examine the functional change of the glomerulus level in CKD by performing 3D reconstructed 
tomography of glomeruli. Several parameters of molecular contents of tissue blocks analyzed by 
multivariate data treatment reveal the key information of stressed glomeruli regarding of the 
microstructure, oxidative stress and the content balance of lipid to protein ratio. We aim to reconstruct 
a 3D FTIR image based on bulk spectral data, to visualize the spatial distribution of a variety of sub-
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molecules of glomerulus and its microenvironment, to further examine pathological changes of the CKD 
development. 
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Abstract: A mouse model of chronic kidney disease (CKD) has been analyzed using a chemical histology 
technique, FTIR imaging, for a 3D reconstruction of glomeruli to determine biochemical and functional 
changes during the pathology development. With 3D reconstructed FTIR imaging on CKD tissue 
specimens, the results showed the loss of glomerular filtration rate along with an increase of lipid 
peroxidation related to oxidative stress, spectral characteristics on lipid molecules and changed protein-
to-lipid ratio. By using BaSO4 microparticles perfused into renal blood vessels, the distribution of BaSO4 
revealed by the spectral integration of 1160-1220 cm-1 spectral interval is used as an indicative index for 
glomerular microvasculature with morphological abnormalities of inner glomerular capillaries. In this 
study, we propose a methodology based on 3D FTIR chemical imaging as a functional histology tool for 
determining lipid peroxidation level and blood vasculature of glomeruli supported by the statistical results 
of 3D spectral data. 
 
Introduction: 
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Chronic Kidney Disease (CKD) is a health problem in the world, and has rare symptoms that are 
detected before the appearance of severe pathological signs with the combined complications [18]. In 
the U.S., there is a higher prevalence of 10.6 % in the earlier stage (stage 1, 2 and 3) of CKD than the 
moderate stage (stage 4, 0.2 % prevalence) or late stage (stage 5, 0.1 % prevalence) by estimating the 
GFR [3]. More than 11 % percentage of Americans aged over 65 year old have CKD at stage 3 [150]. 
The progression of CKD eventually leads to the end-stage renal failure (classified as stage 5), which 
causes the permanent loss of kidney function, and the patients are treated with the options of taking 
renal replacement treatments (either dialysis or transplantation), which increases the load on financial 
issues in national policy. Additionally, the death rate of the population with stage 4 of CKD is up to 45.7 
%, while for the stage 2 and 3 the rate is less but still significant, with 19.5 % and 24.3 %, respectively 
[151]. The statistics gathered in analyzing the mortality and clinical treatment of people with CKD of mild 
to moderate stages indicates that death is more common than the rate of renal replacement treatment, 
which is less than 2 % for stage 2 and 3, respectively, and nearly 20 % for stage 4. 
 
Many systematic disorders affect kidney function by altering the glomeruli, the functional part of renal 
unit nephron, which performs selective ultrafiltration for body clearance and the maintenance of 
systematic balance. A variety of etiological factors contribute to glomerular injury, such as genetic 
disorders, microenvironment stress, microorganism infections, uptake of harmful material as well as the 
physiological decline of activity due to aging [1, 152]. Progressive glomerular injury in CKD represents 
the consequences when partial glomeruli are damaged, which generally are affected by tubular atrophy 
due to proliferated fibrosis in the renal interstitium, and the response of compensatory hyperfiltration of 
glomeruli in remaining nephrons due to the loss of sufficient nephrons. Histopathological patterns of 
glomerular change have two categories in morphological abnormalities, with variation in glomerular size 
and vasculature structure, and functional disorder with impaired selectivity in filtrating materials. Both 
types of features on glomerular disorder is involved with extent of severity in kidney damage. Hence, to 
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diagnose and manage glomerular injury, referring to impaired kidney functions should incorporate the 
analysis in morphometric aberration and molecular dysfunction. 
 
The current method to evaluate the level of glomerular damage depends on either the level of glomerular 
filtration efficiency or the appearance of proteinuria attributed to the impairment of glomerular barrier. 
Nephron number, and the filtration rate in each nephron determinate GFR value. Both indicators are 
involved with body matrices. In some glomerular disease, the diagnosis requires the renal biopsies to 
estimate the expression and states of biomolecules correlated with the pathological change which 
cannot be indicated by blood or urine. However, the lack of morphometric information remains the 
reason of insufficiency in the diagnosis of glomerular disease. As this regards the need for a reliable 
method to assess glomerular injury, it raises the priority of performing quantitative analysis that is 
coupled with imaging capability, to provide the support in morphometric information. 
 
Many research results in laboratory and clinical studies have demonstrated that Fourier-transform 
infrared (FTIR) spectral imaging is capable of discriminating chemical changes in biological specimens 
[114, 142, 153]. This technique is based on the absorption of IR photons by molecular bonds, with a 
specific spectrum of all absorptions occurring for a given biomolecule. For a biosample, for instance a 
tissue, it provides a global view of all its chemical compounds [97]. It thus provides a non-supervised 
recognition tool of chemical changes in biosamples, and thus allows investigations of various 
pathological conditions where molecular parameters are modified or affected. By using an analysis by 
FTIR imaging, it is feasible to monitor the variation in the structure and the property of biochemical 
features, including nucleotides, proteins, lipids, and carbohydrates. Thanks to reagent-free methods, 
the advantage of an FTIR imaging for preserving biochemical contents in their native state allows for 
measuring quantitative and structural changes of physical and chemical characterization on pathological 
specimens [112]. To that end, numerous algorithms have been developed to unravel the chemical 
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changes found in spectra, such as spectral clustering classification, principal component analysis (PCA), 
partial least square (PLS) calibration, curve fitting to extract individual absorption bands from 
spectra…etc [154-157]. For tissue section analysis (called 2D FTIR imaging), this allows us to map 
chemical parameters with a quantitative value, thus making it possible to determine the distribution of 
concentrations [158, 159], of molecular structure changes [160, 161], and even of biochemical 
parameters, such as oxidative stress [162, 163]. However, the limit at using 2D FTIR imaging is that it 
does not provide details on spatial distribution of tissue sub-structures, such as blood and lymph vessels, 
cellular organization and arrangement…etc. 
 
Recently, an approach of 3D FTIR imaging has been proposed [164] to visualize the compositional 
information of thick samples, to improve the expansion of spectral analysis. The procedure to perform 
data acquisition is currently used to collect a series of tissue sections to obtain their corresponding 2D 
FTIR images, before completing a 3D stacking. The development of a 3D FTIR image reconstruction 
methodology would change the face of chemical microscopy for a multidimensional analysis of tissue 
contents, combining both the anatomical and molecular parameters of tissues from the same spectral 
data cube. Slice to slice stacking of 2D spectral would thus offer a more practical way to acquire a global 
analysis of tissue contents in laboratory for biomedical research as well as for clinical applications. 3D 
IR reconstructed images offer analytical performances of choice to understand the development of CKD 
at the glomerulus level, with a microscopic approach of the tissue sub-structure (few microns), and 
potentially a global chemical analysis of biochemical, structural, and functional features if a methodology 
is developed accordingly. The functional aspect can be obtained by using an imaging contrast agent 
perfused in the blood system, thus allowing us to appreciate the GFR at its smallest level. 
 
We used an animal model of mice subjected to unilateral ureteral obstruction (UUO) to study the CKD 
pathological development at the glomerulus level by FTIR imaging. Complete UUO initiated a sequence 
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of decreased renal functions in the obstructed kidney with respect of timing, severity and duration while 
avoiding the interference of chemical materials, genetic engineering and viral/bacterial infection [165-
167]. The aim of present work is to develop a methodology of analyzing progressive renal tissue on the 
basis of infrared imaging with quantitative chemical information and 3D visualization capability. In our 
results, 2D and 3D reconstructed FTIR images provided functional and biochemical analyses from the 
same dataset. Spectroscopically, the change in the ratio between lipids and proteins, the increased lipid 
peroxidation, and filtration change in glomerular vasculature (using perfused contrast agent BaSO4) on 
glomerular disorder is discriminated, which reveals the pathological variation of glomerular disease in 
the progression of CKD. 
 
Method and materials 
Animal experiment and tissue sample preparation 
All animal experiments are performed in male B6/C57 male mice strain of 8 weeks, purchased from the 
National Laboratory Animal Center, Taipei, Taiwan. Complete UUO surgery is operated in the right 
kidney of each mouse after being anesthetized with a mixture of isoflurane and oxygen. The advantage 
of the UUO animal model used to study CKD is that the consequence of histopathological events after 
UUO is highly predictable and reproducible within a short-term stage (usually within two weeks). In 
present studies, BaSO4 microparticles suspended in PBS are perfused into blood vessels of each kidney 
of a mice, which have been perfused with PBS for removing blood, subjected to UUO and without the 
operation, respectively, in 4, 9 and 14 days after UUO. After their death, the kidneys excised are 
immediately frozen in liquid nitrogen for later microsectioning by cryo-microtome. Serial sections are cut 
in 10 m thickness under -20 C by cryostat and then placed on IR-transparent CaF2 substrates for 
further FTIR chemical imaging after air-drying for a few minutes at room temperature. 
 
FTIR data acquisition and data processing 
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All FTIR image data of air-dried renal specimens was recorded in the spectral interval of 900-3900 cm-
1 in transmission model with Bruker Hyperion-3000 FTIR microspectroscopy, equipped with a 64 x 64 
pixel FPA detector with a field of view of 167 x 167 m2. The background data is recorded in the blank 
area outside the tissue deposition in CaF2 window. Each spectrum on one FPA FTIR image in 4096 
pixels was obtained with 500 scans at 4 cm-1 resolution. All spectral processing and classification is 
performed using Kinetics and “Cluster Menu”, written by our group members, in Toolbox of MATLAB2012. 
The data processing is operated on the entire spectra of imaging data sets, not truncated spectra. The 
subtraction of baseline correction in each spectrum uses 6 reference points at 925, 1800, 2100, 2500, 
2700 and 3700 cm-1.  
 
Spectral clustering analysis 
Clustering classification provides a direct identification via the reduction of complexity in sample to 
evaluate the biochemical feature and the content of various tissue components in specimens. The 
advantage of clustering characterization in spectral data is that this data treatment is performed on 
unsupervised data to discriminate the spectral difference of raw spectrum. The level of spectral similarity 
in spectral shape and magnitude shared in individual spectra of matrix is the estimating standard of 
assigning the spectra to its belonging cluster.  
 
The selected spectral interval for algorithms by clustering analysis is at C-H stretching region (2800-
3050 cm-1) for F.A.C. absorption and at BaSO4 donating region (1160-1220 cm-1), respectively. 
Application of spectral clustering is performed on background corrected image data with normalization 
in Amide I region. Every spectrum plotted as a square pixel on resulting image in the FTIR map is coded 
as a false color square corresponding to its assigning membership of its belonging cluster.  
 
Curve fitting 
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The Curve fitting algorithm provides detailed information of chemical components attributed to individual 
bands in FTIR spectrum. The spectral parameters including wavelength of bands, amplitude (peak 
height), band-width and band shapes, which possess unique features representing a discriminative 
vectors of biochemical variations in tissue. The performance of curve-fitting in spectra of FTIR image 
data is operated point to point by auto-algorithm in MATLAB software. To localize the position of 
subpeaks of assumptive bands, which is always fixed, it is obtained by secondary-derivative analysis to 
enhancing the separation of overlapping bands in spectrum. Thus, curve fitting provides the multiple 
compositional information of spectra on FTIR imaging.  
 
A spectral interval of interest in 2787-3115 cm-1 corresponding to the CH stretching region has 
undergone the performance fitting treatment by using 27 component bands for the best fitting in tissue. 
The area of fitted bands provides the quantitative information of samples, which is more specific, to 
justify the concentration of constitutions than integration of border spectral interval. The band peak 
located at 2925 cm-1 and 3014 cm-1 stand for asymmetric CH2 group and olefinic -C=CH group, 
respectively. 
 
3D FTIR imaging construction 
The 3D visualizing of glomeruli composed of a series of tissue sections is constructed by stacking 
adjacent 2D FTIR images after the multivariate approaches. The alignment work before each successive 
2D image stacking is performed to correct the image position of each adjacent spectral data for 
generating an accurate distribution of biochemical content in tissue. The spectral range for the 
integration to present the absorbance of SO4 group of BaSO4 microparticles is set in the region of 1160-
1220 cm-1 for the purpose of revealing the spatial distribution of the amount of perfused BaSO4 
microparticles correlated with the anatomic alternation of glomerular capillary. The resultant 3D volume 
render imaging was plotted as 256 color-coded palettes, and smoothed by using Gaussian interpolation 
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processing. Through representing the 3D spectral features revealed by cluster classification, each 
resultant 2D cluster map is assigned with a constant color that displays the geometric information, not 
the quantitative indication before 3D image rendering. 
 
Result and discussion 
Variation of biochemical compositions on renal specimen in UUO model 
Two spectral intervals of 2800-3050 cm-1 and 1600-1700 cm-1 on FTIR image are used to calculate their 
integrated area for estimating the lipid and protein content, respectively, on all renal biopsies of 
obstructed kidneys. As shown in Figure 18, chemical imaging allows for the visualization of the 
distribution of lipid and protein on renal samples, respectively. Both lipid and protein content are more 
enriched in the glomerular area than in any other non-glomerular area of all renal samples, including the 
obstructed kidney and the normal kidney by representing FTIR image with false color code. Interestingly, 
there is obviously an increasing lipid to protein ratio on glomeruli in an obstructed kidney after 4 days of 
obstruction compared to a normal kidney. In the duration of extended renal obstruction, the ratio on 
glomeruli in an obstructed kidney then returned down to levels similar as in a normal kidney. At day 14 
of UUO, it became a more homogeneous state of lipid to protein ratio on whole tissue section, which 
was distinguished from other obstructed renal samples and normal renal samples.  
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Figure 18. The variation of biochemical content in the kidney of UUO mice. (A) The FTIR spectral images 
display the quantitative information of lipid and proteins by integrating the spectral interval of 2800-3050 
cm-1 and 1600-1700 cm-1, respectively, in renal samples. The value representing the molecular content 
is the integrated area under the selected spectral interval in each spectral pixel of FPA image. (B) The 
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average infrared spectra of 4096 individual spectra in FPA image data. The spectral range displayed is 
1400-3800 cm-1. 
 
In respect to the statistical analysis on the FTIR spectral image, the change of molecular components 
of a kidney with CKD was evaluated by measuring the average lipid-to-protein ratio in all renal samples. 
The data treatment analyzed a series of 2D spectral images, generating the successive 2D result from 
a cubic tissue compared with single 2D result of the central tissue section of glomeruli. Firstly, the whole 
renal tissue is taken for evaluating, to examine whether there is a difference in variance of biochemical 
components in each sample. Figure 19 shows the statistical results of the lipid to protein ratio by 
integrating spectral interval corresponding to total lipid and amide I, respectively, in each FTIR data of 
all biopsies. The result indicates that spectral analysis in molecular contents of each successive 
specimen is capable of discriminating the biochemical change of CKD induced by UUO in our renal 
study. By looking closely at the spectral variance in glomeruli in figure 19C, the result from successive 
2D data shows a large increase in lipid to protein ratio on glomeruli in the 4-day obstructed kidney, 
compared to either the normal kidney or the contralateral kidney. The same result is demonstrated in 
the FTIR image data represented in false color in the last right-hand panel of figure 18. The advantage 
of this approach is that successive 2D FTIR data provides an insight directly estimating the change of 
biochemical composition, either in whole tissue or functional unit glomeruli in a geometric viewpoint 
during the development of renal disease.  
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Figure 19. Statistical pattern of lipid to protein ratio in renal specimens of UUO mice. The average ratio 
is representative of the intensity of lipid to protein on (A) the central section of whole renal tissue (B) 
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successive sections of whole renal tissue (C) successive sections of glomeruli. There are 4096 spectra 
in each FPA of renal specimen. P < 0.05. * vs. Normal. $ vs. Obstructed. a vs. 4d. b vs. 9d. 
 
The same approach is performed to study the variation of chemical state within F.A.C. molecules in renal 
samples, by curve fitting to evaluate the intensity and characteristics of individual bands in the CH 
stretching region. In our study, the ratio of the intensity at 3014 cm-1 and 2925 cm-1 is computed to 
monitor the lipid peroxidation reflecting oxidative stress, which is reported to have significantly increased 
in the UUO model [168]. The result of analyzing each spectra of whole renal tissue indicates the ratio is 
increased in an obstructed kidney and its contralateral kidney after 4 days, compared to a normal kidney 
shown in Figure 20. However, in the early stage of 4 days after the obstruction, oxidative stress in the 
glomerular area of a contralateral kidney increases more than in obstructed kidney, which maintains 
similar levels as in the normal kidney.  
 
The result of our study in the UUO model, investigated by spectroscopic imaging, shows that oxidative 
stress is significantly enhanced in the obstructed kidney and its contralateral kidney when regarding 
mice subjected to UUO treatment. Lipid peroxidation worsens in the obstructed kidney during the middle 
stage of UUO, and this was found by analyzing both whole renal tissue and the glomerular area of the 
renal specimen. For monitoring the pathological state of glomeruli, the significant point showed in the 
data is that more peroxidation expression was observed in the contralateral kidney, not in the obstructed 
kidney, of the mouse with CKD induced by UUO.  
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Figure 20. The unsaturation level of fatty acid chains molecules in kidney of UUO mice. The average 
ratio is representative of the intensity of bands at 3014 cm-1 and 2925 cm-1 on (A) the central section of 
whole renal tissue (B) successive sections of whole renal tissue (C) successive sections of glomeruli. 
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There are 4096 spectra in each FPA of renal specimen. P < 0.05. * vs. Normal. $ vs. Obstructed. a vs. 
4d. b vs. 9d 
 
Glomerular injury scoring 
In order to evaluate glomerular function in CKD, multivariate approaches of FTIR imaging is carried on 
to differentiate distinct tissue structures in glomeruli. Perusing the contrast agent, BaSO4, helps to image 
the vascular network in nephrons and to quantify the glomerular injury, as well as to trace the localization 
of glomeruli in a serial of renal tissue sections. 
 
We took two methods to measure quantitatively the glomerular scoring in obstructed kidneys and its 
contralateral kidney in each mouse. In the examination of the morphometric changes on each 
glomerulus, the spectral integration method is applied on each FTIR image of a series of specimens in 
the spectral interval of 1160-1220 cm-1, assigned majorly to the absorbance of BaSO4 microparticles. 
The reason of choosing the spectral interval mentioned above is because the integrity area of averaged 
spectra is between 1160 and 1220 cm-1 in renal tissue, and when perfused with BaSO4 microparticles it 
is over twice as big as in non-perfused renal tissue shown in Figure 21. Thus, the integrity intensity in 
the spectral interval of 1160-1220 cm-1 can show the most significant difference, compared to the other 
spectra intervals in the 995-1220 cm-1 range. 
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Figure 21. Average infrared spectra from renal specimens treated with or without BaSO4 perfusion. The 
solid line is representative of the BaSO4 treatment, while the dashed line is for the specimen without 
treatment. The spectral range for BaSO4 is between 1160 cm-1 to 1220 cm-1.  
 
Spectral integration of representing signal intensity in 1160-1220 cm-1, donated by a SO4 group of BaSO4 
microparticles is a simple and useful way to clearly locate the position of glomeruli in a serial renal 
section. Figure 22 is the result showing the volume change of glomeruli caused by the kidney obstruction. 
The reduction of glomerular size in a obstructed kidney is up to 30 % at day 4, and continued up to 70 
% at day 9 compared to the measurement of control group mice without surgery. At day 14, the 
obstructed kidney showed 70 % reduction of glomerular size, with no further shrinkage undergoing. It 
can be suspected that the critical value of glomerular size was reached when kidneys suffered the 
physiological stress. In the contralateral kidney of each group, enhanced growth on glomerular size was 
observed when a 30 % increase of the volume was found both at day 4 and day 9. Then, in 14 days, a 
decrease of glomerular volume appears, following the early-stage growth. These results show that 
obstruction in the kidneys lead to glomerular volume reduction, while a comprehensive growth is 
stimulated in its contralateral kidney. 
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Figure 22. The variation of glomeruli volume in kidney due to UUO. 
 
The second is determined by verifying spectral characteristics in tissue samples through clustering 
analysis. In our work, the CH stretching region (2800-3050 cm-1) is used in the analysis, which is 
dominated mainly by the acyl chain of lipid molecules. In our study, 4 assemblies in clustering 
classification are applied to the data of obstructed kidney from 0 to 9 days, and were set in data 
processing as increased number of clusters was attributed to periglomerular tissue and normal 
glomerular composition (Figure 23 A). In this figure, the population of the black cluster was raised on 
the glomerular region in the obstructed kidney after 4 days, and in the contralateral kidney after 9 days 
of the obstruction, respectively. The spectral intensity of the black cluster’s response to enhanced stress 
by the obstruction is generally lower than the other three clusters in most of the spectral frequency of 
CH stretching regions shown in figure 23 B. We further statistically examine the stereological change of 
the spectra feature (coded in black color) on the glomerular region in each group (Figure 24). The result 
shows a 2.37 fold increase of spectral feature in CH stretching region on glomeruli in the 4-day 
obstructed kidney, following the reduction to one-third in day 9 compared to a normal kidney. The 
histopathological state of CKD induced by UUO is thus stereologically elucidated by verifying the 
biochemical information of whole glomeruli. 
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Figure 23. Spectral feature on the F.A.C. region in UUO mice. All FTIR data is treated with clustering 
classification in the spectral interval of 2800 cm-1 to 3050 cm-1. Ctrl is represented by the contralateral 
kidney of the mice subjected to UUO. Obst is representative of the obstructed kidney. Control mouse is 
harvested without the surgery, marked as normal. (A) shows the bright field image, and the 
corresponding image of clustering results in 4 clusters. (B) is the average spectra of each cluster in renal 
samples analyzed in (A). 
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Figure 24. Stereological variation of spectral feature of glomeruli in UUO mice. The ratio is 
representative of the percentage of spectral feature on the F.A.C. region on glomeruli vs tissue unit. The 
normal kidney is labelled as a blank column. Black is for the obstructed kidney, while the sloped-dashed 
line is for the contralateral kidney. 
 
3D imaging of glomeruli with multiple purposes 
As discussed above, 2D FTIR imaging of glomeruli in CKD were investigated either by clustering 
analysis or by curve fitting, revealing the distribution and content changes of chemical components 
following the progression of CKD. The next aim is to acquire spatial information of glomeruli in the matter 
of quantity, and also the geometry on consecutive tissue specimens. Figure 25 A shows the FTIR image 
of glomeruli based on integrated absorbance that is mainly dominated by perfused BaSO4 microparticles 
(1160-1220 cm-1). The change in the vasculature network of glomeruli in the development of CKD is 
discriminated. A more compressed form of glomeruli vasculature architecture was observed in the 
obstructed kidney at day 4, compared to a normal kidney, which exhibited a loose wrap of capillary 
vessels through moving 3D imaging (Supply material). Further examination (Figure 25 B) of 3D spectral 
features in the C-H stretching region (2800-3050 cm-1) on glomeruli was plotted, showing the 
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stereological distributions of identified clusters sensitive to stress induced by UUO, which is discussed 
in figure 23. Significantly geometric alternations in the localization of chemical groups on glomeruli is 
revealed by 3D FTIR imaging in our renal study. Merging the image data shows the change in 
stereological information on glomeruli under pathological stress (figure 25 C). Hence, the combination 
of more than one set of 3D image data indicates the distinct discovery of transformed patterns in 
morphology and physiology on glomeruli, providing a practical way towards multi-imaging approaches 
in handling tissue specimens. 
 
 
Figure 25. 3D imaging of morphological structure and spectral feature on glomeruli in mice after 4-day 
UUO and normal mice. The extracted 3D projection pictures illustrate the glomerular structure based on 
the spectral intensity of BaSO4 microparticles, which are shown in (A), where high levels are shown in 
red, and transparent blue is for low expression. (B) indicates the spectral feature on the F.A.C. region 
on glomeruli by clustering analysis. Merged images in (C) display the correlation and colocalization of 
morphology and biochemical details on glomeruli. Scale bar is representative of 20 m (supplementary 
material provided online). 
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Publication No. 3 (Participation):  
Foreword 
The Inserm U1029 LAMC Laboratory in Bordeaux and the Academia Sinica Nano-X Laboratory in Taipei 
have initiated a collaboration for developing 3D multimodal imaging in biomedical sciences. In Bordeaux, 
the chemical imaging is developed with FTIR microscopy with the aim of providing a global and 
quantitative 3D imaging tool to analyze biosamples. In Taipei, the aim is to develop high-resolution X-
ray tomography of biosamples to analyze the structure and organization of 3D blood network in small 
animal models. They join their efforts in order to develop the first comprehensive technology set, able 
to characterize in detail the development of tumor vasculature and its impact on tumor micro-
environment. Initiated in 2008, this collaboration has led to the development of imaging contrast agents 
usable for different imaging techniques, i.e. contrast agents that are responsive to X-Rays, infrared 
photons and fluorescent. It has also pushed the partners to merge their datasets to perform 3D 
reconstructions of blood vasculature based on different imaging techniques. Lastly, they are developing 
3D data treatment methods for extracting and exploiting the biological information contained in images 
of different origins. The first paper presented here is the starting point of a new avenue for multimodal 
3D imaging, i.e., the development of a common contrast agent that can be used for different imaging 
techniques. 
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Title: Very small photoluminescent gold nanoparticles for multimodality 
biomedical imaging 
Motivation 
As mentioned above, the requirement of obtaining image data by X-ray microscopy relies on the usage 
of contrast agents. It also helps the measurement of IR imaging on biosamples. In recent years, the 
development of contrast agents for imaging techniques has revealed significant improvement in 
improving many aspects of bioimaging, including that of data quality, data treatment and presenting 
better image visualization. With the usage of gold-NPs and barium sulfate microparticles, respectively, 
in X-ray based and IR-based bioimaging, we demonstrate the practical application of these two 
biocompatible contrast materials for the imaging of the microvasculature of glioma, or the long-term 
monitoring of tumor cell growth within the brain. Previous studies and unpublished data in our laboratory, 
as well as collaboration with Taiwan partners, showed that the morphological and/or geometric 
information of gold-NPs and barium sulfate in the blood vessel of brain tumor can be used to distinguish 
tumor growth from the non-tumor tissue, and can also be used to discriminate the tumor types by the 
multimodal imaging of combining X-ray and FTIR. For multimodal bioimaging, image agents have the 
characterization of visualization and quantization for more than one image technique. In this paper, we 
propose the development of a new contrast agent for functional histology, with multimodal properties by 
X-ray, IR and luminescent microscopies. This strategy for imaging quantitatively molecular information 
of examined biosamples could be used to merge multifunctional investigations for diagnosis and 
prognosis in clinics and laboratory research. 
 
Result in this paper 
Very small sized gold-NPs are synthesized by carefully tuning the parameters of the chemical precursors 
and irradiation time by X-ray light source. The dual optical properties of high x-ray attenuation and 
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photoluminescence excitation of these very small gold-NPs (ψ1.4 nm0.3 nm) provides the unique 
capability of performing functional/morphological information in in vivo bioimaging. Proper surface 
chemistry of these very small gold-NPs allows a large amount of internalized gold-NPs in the cellular 
cytoplasm that did not induce in obviously either cellular proliferation, or cellular death. Furthermore, 
appropriate quantitative estimation is highly feasible to study NP content within the tissues. Also, the 
preliminary result implies that the potential of the very small gold-NPs as a drug carriers for therapeutics. 
This multimodal imaging agent characterized with visible light fluorescence and X-ray absorption is thus 
considered as a good imaging tool for histopathological imaging. 
 
Perspective 
Our studies in this paper have shown that a newly developed contrast agent has the dual optical 
properties of imaging capability for functional investigation of histopathology with the respect of disease. 
The approach of using photo-luminescent gold-NPs for functional FTIR/X-ray micro-tomography 
imaging allows for the evaluation of microvasculature related to pathological conditions. Based on the 
spectral information, it can be determined if there is abnormal morphology of blood vessels in the blood 
capillary within the tissue, either with leakage or fenestrae depending on the pathological mechanism of 
disease. Moreover, the vasculature density within investigated tissue can be determined by the 
stereological analysis of 3D X-ray data for studying disease-related angiogenesis. This approach of 
combining imaging technique and appropriate contrast agents may be used to provide a convenient tool 
for routine diagnosis in pathology. 
 
Work description 
The newly synthesized gold nanoparticles with irradiation exposure have multioptical characteristics, 
which are encouraging signs for their potential applications within biomedical research. The first 
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experiment for the biocompatibility estimation was to perform a cellular toxicity assay to directly count 
the surviving cell numbers in cultured cells exposed to our newly synthesized gold-NPs. Loading large 
amounts of gold-NPs into the cultured cells showed photoluminescent signals excited from the cellular 
cytoplasm, indicating that engulfed NPs contributed mainly to the detection of fluorescence light, not the 
attached clusters of NPs on the cell membrane. We also performed the imaging experiment of visualizing 
these very small gold-NPs accumulated in cells by using high-resolution TXM microscopy. The image 
results are not as significant as the ones acquired by confocal microscopy. Thus, the following animal 
experiment of implanting tumor cells pre-cultured with photoluminescent gold-NPs for a few days was 
performed to evaluate the distribution and visualization of these gold-NPs in a subcutaneous tumor 
development. Our results by hard X-ray microscopy showed the contrast signals attributed to the X-ray 
absorption of gold-NPs in inoculated tumor tissue within a small animal. By using confocal imaging, it 
was confirmed that the existence of gold-NPs excited the red fluorescence in the incised tumor region 
of the animal. We can propose that the multimodal properties of our very small gold-NPs are a good 
candidate to be used in biomedical research by X-ray, photoluminiscent or possible IR imaging modality. 
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Publication No. 4 (Participation) 
Foreword 
In this paper, we present a work on structural biology, using FTIR imaging to characterize collagen 
structure changes in glioma development. The methodology developed here also is valuable for studying 
CKD as fibrotic tissue, a main issue in most of renal diseases, developed along CKD physiopathology. 
Participating in this study with PhD students in charge of this project, it was further decided to conduct 
a study on CKD models to import FTIR imaging to Taiwan. Currently, Taiwan does not have a large 
community of spectroscopists, and FTIR imaging is poorly developed (not even present at Academia 
Sinica in Taipei). To strengthen the collaboration between Bordeaux and Taipei, which would take the 
form of an International Associated Laboratory in 2016, it was decided to have PhD level training on 
using FTIR imaging for analyzing glomeruli system in kidney with a 3D chemical imaging perspective. 
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Title: FTIR spectro-imaging of collagen scaffold formation during glioma tumor 
development 
FTIR imaging is demonstrated to be a useful diagnostic tool for characterizing histopathological change 
of diseased tissue specimens in biomedical research. In the development of glioma, it is revealed that 
ECM abnormality is associated with the tumor growth via its physical and chemical effect on 
microenvironment. Collagen is one of the major components of ECM, which is rarely detected in normal 
brain tissue. In this study, it has been found that the differences between glioma and healthy brain 
specimens can be discriminated based on the spectral characteristics of collagen molecules. The 
spectral difference of secondary structure of protein on Amide I region (1700-1600 cm-1) shows that 
collagen content is a unique chemical parameter for differentiating brain tumor. The scaffolding level of 
collagen is found to be related with the progression level of glioma. IR spectral imaging revealed the 
significant observation on the change of collagen amount and folding architecture. By FTIR imaging 
analysis on glioma specimens, chemical change (type, amount and molecular structure) of collagens 
can be used to classify the types of glioma and the tumor development. This finding confirms the 
significant application of FTIR spectral imaging in diagnosis and prognosis via the characterization of 
collagen in brain tissue. 
 
In this work, it was found that the change on spectral intensity of Amide I and II region was 
distinguishable in tumor tissue compared to healthy tissue. On the contrary, lipid content remained stable 
over the period of tumor growth. Spectral curve fitting process is performed to discriminate the 
secondary structure change of protein contents between tumor and healthy tissue, revealing that the 
enlarged bands with the frequency center of 1637 cm-1 corresponding to the triplex structure of collagen. 
With the evidence of statistical result of CFA test on the secondary structure of collagen, it was found 
that the spectral difference between different types of pure collagens can be discriminated successfully. 
The same data treatment was successfully applied on the discrimination of tumor progression of solid 
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glioma based on the spectral information of secondary structure of collagen. Based on the findings of 
micro-organization of collagen contents by FTIR spectral imaging, it is concluded that collagen 
differentiation during tumor growth may be considered as a marker of glioma grade. 
 
Work description 
The approach of this project is to analyze glioma tumor development by IR chemical imaging, through 
characterizing the molecular contents related to glioma development for diagnosis. We use 
nanoparticles as contrast agents to reveal tumor vessels and thus locate the tumor region without 
histology labeling (such as fluorescent dye). Before launching IR data acquisition on tissue specimens, 
the sample preparation for IR imaging is to cut the frozen mouse brain perfused with contrast agents to 
thin sections of 20 μm deposited on the IR transparent substrate. Serial section of mouse brain is 
performed to obtain consecutive three tissue sections of tumor part in each mouse brain to expand the 
spectral data collection in tumor volume. 
 
Learning how to collect FTIR image with low S/N ratio and reproducible data is the priority of obtaining 
raw spectral data for further algorithm analysis. For the data processor to examine chemical band 
information of IR images, we used commercial ready-to-use software, Opus 7.1, to perform the post 
data processing on IR data. Fixed band information of pure product collagens is obtained by curve fitting 
Opus software for the setup of band parameter reference to run the curve fitting on glioma tissue. The 
work of performing curve fitting on pure product collagens provided a good training opportunity to learn 
the advanced algorithm, which characterizes individual bands at a spectral interval. In my project of 
chronic renal disease, curve fitting processing coded by our team members provided the important 
information on chemical content change of F.A.C sub-molecules at glomerulus level and its 
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microenvironment. These results showed that fitting procedure on the analysis of FTIR image data is a 
key step of data processing. 
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Discussion 
The objective of this PhD thesis is to discriminate the chemical parameters and morphological change 
of the renal functional unit, glomeruli, in the kidney of mice with different levels of CKD in three 
dimensions. The model of UUO in the rodents, which establishes the CKD condition studied in this thesis, 
generates a physically induced progressive inflammation in the kidney without the involvement of 
exogenous toxins as well as avoiding the genetic effect. FTIR imaging is considered as a useful tool to 
characterize the molecular histology by analyzing the spectral chemical information in many biological 
samples. Glomerulus has been the research subject in renal studies by many imaging techniques, but 
this complex microvasculature network has not been effectively studied in chronic disease statuses by 
FTIR imaging. The continuing decrease of GFR in CKD indicated that the function efficiency of glomeruli 
is evidently affected in the progression of CKD. Differentiating pathological signatures of disease 
biosamples by FTIR imaging provides nephrologists a tool to investigate the outcome of multiple-stress 
factors such as increased oxidative stress, metabolic disorder, and inflammation at the glomerulus level 
of CKD. Reproducible FTIR data acquisition and multivariate data treatment can provide appropriate 
chemical based information to distinguish the stage of disease in glomeruli between pathological and 
contralateral kidneys of the mice with CKD and healthy kidneys coupled with statistical analysis. The 
characterized absorption information of barium sulfate microparticles perfused in a glomerular vessel is 
used to visualize glomerular morphology and predict the glomerular damage by estimating barium 
sulfate content and their distribution in glomeruli. Although the standard pathological information about 
glomeruli of CKD is lacking in this study as there are no approaches to reach the complex biochemical 
conclusion of renal pathology. Our study of comparing healthy and pathological glomeruli of CKD can 
provide the 3D chemical/molecular conclusion of glomeruli on fundamental renal research based on 
spectral analysis coupled with statistical data treatment. The aim of this PhD thesis project on renal 
study is to access the histopathological application of 3D FTIR imaging on scientific research and further 
explore it to the routine use in medicine. 
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In this study, we research the molecular differences of the glomerulus level of the kidney with CKD based 
on FTIR imaging. At first, the molecular content based on the intensity of spectral absorption is 
investigated to evaluate the chemical parameters of lipid and protein in renal specimens. The finding 
has shown that the ratio of lipid to protein in pathological glomeruli is different to healthy glomeruli. 
Although the absolute IR absorption of lipid and protein in glomeruli does not reveal significant change 
between pathological and healthy specimens, the relative expression between two molecular content is 
sufficient to discriminate the chemical/molecular characteristics of glomeruli. The discussion of 
metabolic molecules in glomeruli is not studied in this project because of the large overlapping 
phenomenon of spectral absorption between barium sulfate and the carbohydrates within the 1300–900 
cm-1 spectral interval. Strong absorption of barium sulfate microparticles masks the weaker spectral 
information of metabolic factors such as glucose, glycogen, and lactic acid within the tissue. The work 
on subtracting IR absorption attributable to barium sulfate microparticles in renal specimens is the future 
subject in researching the metabolic information of CKD in kidney. 
 
Another subject in this project is the investigation of IR absorption change of phospholipids in renal 
specimens associated with oxidative stress in CKD. The increasing oxidative stress correlated with the 
severity of renal failure involves the level of lipid peroxidation [169]. We use curve-fitting process based 
on the spectral interval of 3050-2800 cm-1 to perform quantitative analysis of ν(=CH), νas(CH3), and 
νas(CH2) bands for their characteristic band absorption of fatty acid chains. This performance allows 
the oxidative damage on lipids to be quantitatively calculated on the basis of the ratio ofν(=CH) toν
as(CH2), the unsaturation level of lipids. The change of unsaturated lipids provides a direct measurement 
of oxidative stress in pathological kidneys with different severities of CKD, its corresponding contralateral 
kidneys and healthy kidneys of the control mice. Although the global detection of oxidative stress in 
clinical examination are not currently accessible because of the instability of some ROS of oxidative 
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stress and their short half-life, the oxidation target end products including peroxidized lipids formed due 
to the reaction of ROS with biomolecules are more stable as well as detectable in many biosamples with 
pathological conditions [170]. 
 
In the statistical results on the basis of 2D consecutive measurement of IR absorption and further data 
treatment, the findings were to demonstrate that 3D FTIR imaging is able to reach the stereological 
spectral discrimination of glomerular and global renal specimens. We found that the percentage of 
peroxidized lipids in glomerulus is increased in both pathological kidney and contralateral kidney 
compared to healthy kidney in the progression of CKD. Second, the distribution of perioxidized lipids is 
different from the pathological kidney to the contralateral kidney of mice with CKD. The distribution 
pattern of increased peroxidized lipids is increased from periglomerular tissue to glomerular tissue in 
pathological kidney in the development of CKD, while the opposite happens in a contralateral kidney. 
Therefore, this study has shown that 3D FTIR imaging is able to distinguish the pathological change 
between pathological and its contralateral kidney of the mice with CKD as well as between contralateral 
kidneys of the mice with CKD and healthy kidneys of control mice. We also found that the 3D 
characterized spectral feature of glomeruli in the 3050-2800 cm-1 spectral interval may be a predictable 
parameter of pathological stress at the early stage of CKD. Combined with the above findings about 
glomeruli of CKD on chemical parameters, FTIR imaging coupled with stereological analysis is a 
potential diagnostic tool of determining pathological status of glomeruli related with progressive renal 
disease. 
 
The last step of this study is to use 3D FTIR imaging data to build the visualization of morphometric 
information of glomerulus level for the functional discrimination between pathological kidneys and 
healthy kidneys. We use integrated intensity of IR absorption of barium sulfate perfused in renal 
microvasculature as the functional parameter to examine glomerular morphology. The chemical 
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parameter based on the spectral characteristics of C-H stretching region (3050-2800 cm-1) of the 
specimens is used to co-localize with the morphological parameter generated from barium sulfate 
intensity for creating the 3D multiparameter FTIR imaging of glomeruli. This 3D plotting of FTIR imaging 
approach shows the correlation of the internal anatomy of the glomerular vasculature and the molecular 
information of pathological state of glomeruli. The report on UUO models proposes that the obstruction 
may cause the microvascular injury based on the observation of thickening epithelial layer of glomeruli 
[171] as well as the reduction of renal blood flow contributing to the changes in vasculature of the 
obstructed kidney [172]. In the present study, 3D FTIR imaging has the potential of being a useful tool 
to quantitatively investigate the 3D vascular morphology and functional parameter of glomerulus level 
based on one spectral dataset. 
 
The weakness in the present study is in its uncertainty of the relationship between the severity of CKD 
and the spectral histopathology, although it is highly possible to demonstrate the association between 
chemical information based on successive spectral dataset and glomerulus unit of the kidney. The small 
sample size of received biological specimens and minimum number of glomeruli which is completely 
collected for a successive dataset acquirement in each mouse kidney are the reasons with respect to 
the confident statistical conclusion. Though the –CH stretching region on 3050-2800 cm-1 is used to 
determine chemical change of glomeruli during the progression of CKD, other spectral interval 
containing more complex absorption bands such as fingerprint region for Amide absorption is not 
discussed in this study. On other hand, the lack of specific biomolecular evidence to support 
histopathological determination is another issue when considering FTIR as a histopathological tool 
because all spectrometric evaluation of biosamples is based on mathematical computing. 
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Conclusions & Perspectives 
In our study, we used FTIR microscopy developed as a 3D reconstruction imaging method to investigate 
histopathological change of CKD on the basis of chemical parameters of glomeruli on the spectral 
interval of –CH stretching region (3050-2800 cm-1). We demonstrated that the 3D quantitative analysis 
of chemical parameters can be obtained. The methodology developed can be automated so that 
diagnostic applications can be predicted in a clinical routine. Several key-parameters of renal diseases 
can be investigated, thus giving sense to the development of routine tools in the future. The spectra 
information of molecular content and/or the chemical change of fatty acid chains in phospholipids help 
to distinguish glomerular tissue from non-glomerular tissue, which may be an important capability in 
disease diagnosis. Using appropriate data treatment on 3D spectral data, we demonstrated that 
pathological and healthy glomeruli can be effectively discriminated based on the statistical difference on 
the unsaturated lipid level and spectral characteristics. The glomerular filtration rate can be also 
determined using appropriate contrast agent, in this case, BaSO4 nanoparticles, which is an accepted 
chemical for human investigations. It remains to be demonstrated that this imaging agent can be used 
in pharmacological concentrations in the blood stream for local injections. A biopsy might be sufficient 
to characterize CKD or other renal pathologies at the glomerulus level, which is currently a missing 
diagnostic tool. 
 
From this set of works done during my PhD and other initiatives between the involved Bordeaux and 
Taiwan laboratories, several ambitious projects have emerged to make 3D IR microscopy a major 
method for analyzing tissue volumes in 3D. From biomedical to pharmacological applications, the 
technique will provide unprecedented analytical performances for the 3D chemical analysis of tissues, 
extracting automatically chemical, biochemical, molecular, and sub-structures information from spectral-
derived data. In this framework, the IR microscopy methodology for 3D chemical histology can be 
imported and developed in Taiwan for specific applications, related to CKD, liver cancer and other major 
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pathologies with high prevalence in Asia. The perspectives after this PhD work are thus related to new 
developments, summarized hereafter: 
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Project of International Associated Laboratory – VascView 
3D multimodal imaging of vascular plasticity in human diseases 
Starting Date – January 2016 (4 years duration, renewable once) 
Project (abstract) 
The scientific objective of the IAL VASCVIEW is to use complementary imaging resources 
(morphological/molecular) to study the role of the microvascular plasticity in the development of human 
pathologies. The ambition is to realize an analytical continuum covering the molecular - cellular – tissue 
scales in the characteristic organization of the pathological microvasculature, in particular for incurable 
cancers (glioblastoma, pancreas carcinoma, and lung cancer), and a degenerative pathology (chronic 
kidney disease). These pathologies have in common to be evolutionary by developing an abnormal 
interface between the extracellular matrix, the microvasculature and the cellular metabolism. Because 
of their unpredictable tissue distribution, these parameters can be analyzed only by combining 3D 
imaging techniques, in particular for the morphological and molecular analysis of the pathological organ. 
For each pathology, the analysis in native form of the growth factor - receptor interactions by coupling 
AFM / infrared microscopy at 10 nm of resolution will allow to study the importance of key growth factors 
on vascular plasticity at the single molecule level in native form. Infrared imaging coupled with X-Ray 
tomography will allow to estimate the impact of these growth factors on the construction of healthy and 
pathological capillaries. The same imaging approaches will finally allow to realize a volumetric histology 
at the scale of the whole organ to study the vascular network formed at different stages of the pathology 
progression. 
 
Our technological objective is thus to develop new multimodal imaging (MI) solutions for 3D histology, 
with the aim of realizing a functional volumetric histology, in particular on biopsies, for diagnostic 
purposes in anatomo-pathology. The developed methodologies will also allow studying the efficiency of 
pro- or anti-angiogenic drugs on the vascular plasticity for the treatment of these pathologies. 
 
The main advantage of this IAL is the use of state-of-the-art imaging techniques, in particular for X-Ray 
tomography (bringing unique analytical performances for in vivo and high-resolution imaging on single 
cells and small animals) and for infrared imaging (with specific and unique setups allowing the analysis 
of a single protein in native form or for 3D histology), taking advantage of conventional sources 
(Bordeaux / Taipei) and synchrotron radiation (Taiwan) for complementary studies. This situation, unique 
worldwide, is strengthened by the common development of microscopes, biological models, methods of 
image acquisitions, and solutions of data processing for the characterization of the biological samples 
by multimodal imaging. We thus expect from this strong collaboration that it opens new perspectives for 
the bioimaging and that it helps us to understand the key stages of human pathologies. Another objective 
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of the project is to use the scientific knowledge acquired to propose new R&D strategies, notably for the 
industrialization of infrared and X-Ray Benchtop instrumentations and their applications in biology. 
 
Project accepted by Academia Sinica (TWN) on March 2015, and Inserm (FRA) and Univesity of 
Bordeaux (FRA) on July 2015. 
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ITEA3.1 European Project – 3Dpathology 
Developing 3D Digital Pathology with Spectroscopy 
Accepted - starting date January 2016 (for Taiwan) – Oct. 2015 (for France). 
Project (abstract) 
According to Frost & Sullivan1,2, the digital pathology market is forecast to grow from $546 million in 
2014 to $3.1 billion in 2020. This is based on an estimated of CAGR of 23.1%. This growth, combined 
with a decreasing number of qualified pathologists will lead to a tremendous increase in workload in 
pathology departments of clinical and pharmaceutical organizations. On top of this quantitative 
expansion there is urgent need for higher quality diagnostic information, which enables more effective 
and efficient treatments. 
Clinical opinion leaders have indicated that these needs can best be answered by:  
1) The digitalization of pathology labs to increase the diagnostic capacity of pathology 
departments, and 
2) Improving the quality of diagnosis by the visualization of multi-modal pathology in 3D. 
 
The 3D Pathology project will address these needs by creating a - fast, digital, quantitative, 
spectroscopic, and multimodal - 3D pathology analysis system. 
We foresee that this 3D quantitative digital pathology solution, based on a comb ination of multiple 
existing pathology modalities (a multitude of molecular information is incorporated in the clinical 
workflow), will lead to a far more personalized treatment of cancer and cardiovascular diseases. 
The project will also address clinical workflow integration aspects and standardization of data 
storage and exchange.  
The envisioned digital pathology imaging system will address the analysis and interpretation of the 
inherently complex pathological images with a size of 100+GB per sample (mono-modal). 
Combined with the high throughput rate and huge sample- and system data volume (data sets in 
the range of Terabytes to Petabytes), technological innovations are required of a completely 
different level of complexity compared to other state-of-the-art medical imaging solutions (e.g. 
spectral CT scanners). 
 
Five major software intensive technological challenges are identified and will be cleared in this 
project: 
                                                     
1 “US and European Digital Pathology Systems Market”, Frost & Sullivan, June 2013  
2 “Analysis of the Digital Pathology Market in China”, Frost & Sullivan, April 2014 
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1- Fast and automated 3D acquisition of tissue information using multiple imaging modalities; 
2- Fusion of the data acquired by different modalities (different size, different resolution in all 
directions, different storage format, different spectral bandwidth), which includes techniques 
like co-registration, alignment, reconstruction. 
3- Efficient analysis of the aligned 3D data from different imaging modalities. To enable a high 
quality diagnosis, the entire tissue sample needs to be analyzed in detail, complemented 
with patient data. Fast big data analysis algorithms (machine learning and data mining) will 
be developed to extract and combine the relevant data. 
4- Design of new 3D visualization and interaction technologies (equipment and algorithms), 
optimized for multi-modal 3D pathology. 
5- Provide an IT backbone to handle the data of tremendous size produced by the individual 
imaging modalities (data sets in the range of Terabytes to Petabytes).  
 
The consortium is headed by three major European equipment suppliers (Barco, Bull and Philips), 
who, together with other equipment, software and service suppliers in this consortium bring 
complementary solutions and services to the market required to establish the complete multi -model 
3D pathology pipeline envisioned (e.g. microscopes, scanners, IT infrastructures, datacenters, 3D 
image manipulations, research  tools, diagnostics algorithms, medical training). 
In addition, the three major users (dominating the market in the histology domain) are also 
represented in the consortium (hospitals and pathological laboratories). 
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ITEA3.2 European Project – DrugsInOrgans 
3D Digital Imaging for Systematic Drug Testing 
Submitted Oct.2015 – starting date July 2016. 
Project (abstract) 
The R&D costs for new therapeutic drugs have raised dramatically over the past two decades, 
making that major pharmaceutical and biotechnology companies now spend €10.5 billion or 22% of 
total annual R&D costs on preclinical research, i.e., more than the total spent on Phase I and II 
activity combined. The preclinical phase includes more and more analyses to check the adverse 
effects of drugs, and histology is required for safety, pharmacology, pharmacokinetics, and general 
toxicology, studies. Histological studies represent a major weakness in preclinical studies as they 
remain limited to the 2D visualization of a limited number of parameters. Accessing to the 3D 
organization of organs in small animal models would change drastically this situation, with 
chemical, morphological, and functional parameters of interest.  Only chemical microscopy 
techniques can achieve this analytical performance, but they also generate massive datasets that 
are not currently managed by 3D image software products. 
The aim of DrugsInOrgans is to propose an innovative ecosystem for the preclinical 
validation of pharmaceutical products, with the double advantage of a reduction of R&D costs 
for companies developing therapeutic molecules as well as an enhancement of the drug candidates’ 
selectivity before starting clinical trials. In the first case, it is due to the systematic screening of 
effects of drugs on vital organs in small animal models. In the second case, the aim is to provide a 
new analytical standard, 3D chemical microscopy, currently unemployed in pharmacology. The 
main technical challenge is not analytical (3D microscopy by spectroscopy), but rather mathematical 
(HPC on massive image data) and related to the management and safety issues of big data.  
The innovation lies in the implementation of a technological platform able to handle the acquisition, 
the processing and the interpretation of 3D chemical images, i.e., fresh ideas at present unavailable 
in pharmacology. The major contribution will be to introduce a systematic analysis of the 
effects of therapeutic molecules, both on the chemical composition of tissues as on their 
morphology and functions (metabolic, biochemical ...). The techniques of 3D microscopy will 
be complementary (mass, IR/Raman, X-ray fluorescence) and will cover the whole parameters of 
interest to characterize the possible toxicity of tested molecules. The platform will include a set - 
HPC, datacenter, software suite - that will allow to compare 3D chemical images (references vs. 
tests) and to reach routines for data treatments and their 3D visualization, the whole in an open 
source fashion to facilitate collaborations between companies, where relevant. 
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The envisioned digital imaging platform will address the analysis and interpretation of the inherently 
complex pharmaceutical= images with a size of 100+GB per sample (mono-modal). Combined with 
the HT rate and huge sample and system data volume (data sets in the range of Terabytes to 
Petabytes), technological innovations are required of a completely different level of complexity 
compared to other state-of-the-art bioimaging solutions (e.g. spectral and CT scanners). 
 
Five major software intensive technological challenges are considered in this project: 1- Fast and 
automated 3D acquisition of small animal organs’ information using chemical imaging modalities; 
2- Efficient analysis of the aligned 3D data from different imaging modalities. To enable a h igh 
quality drug testing, the entire organs will be analyzed in detail, complemented with reference 
analyses (histology…); 3- Fast bigdata analysis algorithms (machine learning and data mining) will 
be developed to perform mathematical treatments and extract the relevant data; 4- Design of new 
3D visualization and interaction technologies (equipment and algorithms), optimized for drug testing 
and validation; 5- Providing an IT backbone to handle the data of tremendous size produced by 
chemical imaging modalities (data sets in the range of Terabytes to Petabytes).  
 
The consortium is headed by major European companies (Bull, Servier, Sanofi, Siveco, PS-Tech… 
and from associated countries – CAN, USA, TWN), which, together with other equipment, software and 
service suppliers in this consortium bring complementary solutions and services to the market required 
to establish the complete technology pipeline envisioned for the pharmaceutical industry (e.g. 
microscopes, datacenters, 3D image manipulations, IT infrastructure safety, research tools). The 
securing of experimental data will be specifically handled to ensure a complete preservation of I.P. for 
pharmaceutical companies.  In addition, the major end-users (dominating the pharmaceutical market) 
are also represented in the consortium (biotech and big-pharma companies) and cover the major 
pharmaceutical regulations found in Europe, North America and Asia. 
  
114 
 
 
Reference 
1. Levey, A.S. and J. Coresh, Chronic kidney disease. Lancet, 2012. 379(9811): p. 165-80. 
2. Zhang, Q.L. and D. Rothenbacher, Prevalence of chronic kidney disease in population-
based studies: systematic review. BMC Public Health, 2008. 8: p. 117. 
3. Coresh, J., et al., Prevalence of chronic kidney disease in the United States. JAMA, 
2007. 298(17): p. 2038-47. 
4. Iseki, K., Renal outcomes in chronic kidney disease. Nephrology (Carlton), 2010. 15 
Suppl 2: p. 27-30. 
5. Hsu, C.C., et al., High prevalence and low awareness of CKD in Taiwan: a study on the 
relationship between serum creatinine and awareness from a nationally 
representative survey. Am J Kidney Dis, 2006. 48(5): p. 727-38. 
6. Wen, C.P., et al., All-cause mortality attributable to chronic kidney disease: a 
prospective cohort study based on 462 293 adults in Taiwan. Lancet, 2008. 371(9631): 
p. 2173-82. 
7. Kuo, H.W., et al., Epidemiological features of CKD in Taiwan. Am J Kidney Dis, 2007. 
49(1): p. 46-55. 
8. Su, S.L., et al., Risk factors and their interaction on chronic kidney disease: A multi-
centre case control study in Taiwan. BMC Nephrol, 2015. 16: p. 83. 
9. Zhang, J.L., et al., Functional MRI of the kidneys. J Magn Reson Imaging, 2013. 37(2): 
p. 282-93. 
10. Thomas, S.R., Kidney modeling and systems physiology. Wiley Interdiscip Rev Syst Biol 
Med, 2009. 1(2): p. 172-90. 
11. Eckardt, K.U., et al., Evolving importance of kidney disease: from subspecialty to 
global health burden. Lancet, 2013. 382(9887): p. 158-69. 
12. Tonelli, M., et al., Chronic kidney disease and mortality risk: a systematic review. J Am 
Soc Nephrol, 2006. 17(7): p. 2034-47. 
13. Go, A.S., et al., Chronic kidney disease and the risks of death, cardiovascular events, 
and hospitalization. N Engl J Med, 2004. 351(13): p. 1296-305. 
14. Levey, A.S., et al., The definition, classification, and prognosis of chronic kidney 
disease: a KDIGO Controversies Conference report. Kidney Int, 2011. 80(1): p. 17-28. 
15. Wouters, O.J., et al., Early chronic kidney disease: diagnosis, management and models 
of care. Nat Rev Nephrol, 2015. 11(8): p. 491-502. 
16. Vassalotti, J.A., L.A. Stevens, and A.S. Levey, Testing for chronic kidney disease: a 
position statement from the National Kidney Foundation. Am J Kidney Dis, 2007. 
50(2): p. 169-80. 
17. Levey, A.S., et al., National Kidney Foundation practice guidelines for chronic kidney 
disease: evaluation, classification, and stratification. Ann Intern Med, 2003. 139(2): p. 
115 
 
 
137-47. 
18. National Kidney, F., K/DOQI clinical practice guidelines for chronic kidney disease: 
evaluation, classification, and stratification. Am J Kidney Dis, 2002. 39(2 Suppl 1): p. 
S1-266. 
19. Bauer, C., M.L. Melamed, and T.H. Hostetter, Staging of chronic kidney disease: time 
for a course correction. J Am Soc Nephrol, 2008. 19(5): p. 844-6. 
20. Boubred, F., et al., Developmental origins of chronic renal disease: an integrative 
hypothesis. Int J Nephrol, 2013. 2013: p. 346067. 
21. Yang, H.C., Y. Zuo, and A.B. Fogo, Models of chronic kidney disease. Drug Discov Today 
Dis Models, 2010. 7(1-2): p. 13-19. 
22. Hodgkins, K.S. and H.W. Schnaper, Tubulointerstitial injury and the progression of 
chronic kidney disease. Pediatr Nephrol, 2012. 27(6): p. 901-9. 
23. Tucker, P.S., A.T. Scanlan, and V.J. Dalbo, Chronic kidney disease influences multiple 
systems: describing the relationship between oxidative stress, inflammation, kidney 
damage, and concomitant disease. Oxid Med Cell Longev, 2015. 2015: p. 806358. 
24. Kaissling, B., M. Lehir, and W. Kriz, Renal epithelial injury and fibrosis. Biochim Biophys 
Acta, 2013. 1832(7): p. 931-9. 
25. Lin, S.L., et al., Pericytes and perivascular fibroblasts are the primary source of 
collagen-producing cells in obstructive fibrosis of the kidney. Am J Pathol, 2008. 
173(6): p. 1617-27. 
26. Kato, N., et al., Mapping quantitative trait loci for proteinuria-induced renal collagen 
deposition. Kidney Int, 2008. 73(9): p. 1017-23. 
27. Eddy, A.A., Overview of the cellular and molecular basis of kidney fibrosis. Kidney Int 
Suppl (2011), 2014. 4(1): p. 2-8. 
28. Oberg, B.P., et al., Increased prevalence of oxidant stress and inflammation in patients 
with moderate to severe chronic kidney disease. Kidney Int, 2004. 65(3): p. 1009-16. 
29. McCullough, P.A., A.T. Whaley-Connell, and J.A. Vassalotti, The future of CKD 
detection: the role for the Kidney Early Evaluation Program. Nephrol News Issues, 
2014. 28(4): p. 41-2. 
30. Kriz, W. and M. LeHir, Pathways to nephron loss starting from glomerular diseases-
insights from animal models. Kidney Int, 2005. 67(2): p. 404-19. 
31. Carlstrom, M., C.S. Wilcox, and W.J. Arendshorst, Renal autoregulation in health and 
disease. Physiol Rev, 2015. 95(2): p. 405-511. 
32. Hoy, W.E., et al., A stereological study of glomerular number and volume: preliminary 
findings in a multiracial study of kidneys at autopsy. Kidney Int Suppl, 2003(83): p. 
S31-7. 
33. Hughson, M., et al., Glomerular number and size in autopsy kidneys: the relationship 
to birth weight. Kidney Int, 2003. 63(6): p. 2113-22. 
116 
 
 
34. Johnson, R.J., The glomerular response to injury: progression or resolution? Kidney 
Int, 1994. 45(6): p. 1769-82. 
35. Hallan, S.I., et al., Combining GFR and albuminuria to classify CKD improves prediction 
of ESRD. J Am Soc Nephrol, 2009. 20(5): p. 1069-77. 
36. Hemmelgarn, B.R., et al., Relation between kidney function, proteinuria, and adverse 
outcomes. JAMA, 2010. 303(5): p. 423-9. 
37. Woods, L.L., Intrarenal mechanisms of renal reserve. Semin Nephrol, 1995. 15(5): p. 
386-95. 
38. Chaudhary, K., et al., The emerging role of biomarkers in diabetic and hypertensive 
chronic kidney disease. Curr Diab Rep, 2010. 10(1): p. 37-42. 
39. Devarajan, P., The use of targeted biomarkers for chronic kidney disease. Adv Chronic 
Kidney Dis, 2010. 17(6): p. 469-79. 
40. Fassett, R.G., et al., Biomarkers in chronic kidney disease: a review. Kidney Int, 2011. 
80(8): p. 806-21. 
41. Weissleder, R. and M.J. Pittet, Imaging in the era of molecular oncology. Nature, 
2008. 452(7187): p. 580-9. 
42. Wang, Y., et al., Label-free Au cluster used for in vivo 2D and 3D computed 
tomography of murine kidneys. Anal Chem, 2015. 87(1): p. 343-5. 
43. Beeman, S.C., et al., MRI-based glomerular morphology and pathology in whole 
human kidneys. Am J Physiol Renal Physiol, 2014. 306(11): p. F1381-90. 
44. Hofman, M., et al., 68Ga-EDTA PET/CT imaging and plasma clearance for glomerular 
filtration rate quantification: comparison to conventional 51Cr-EDTA. J Nucl Med, 
2015. 56(3): p. 405-9. 
45. Peti-Peterdi, J., et al., Multiphoton imaging of renal regulatory mechanisms. 
Physiology (Bethesda), 2009. 24: p. 88-96. 
46. Andrews, P.M., et al., High-resolution optical coherence tomography imaging of the 
living kidney. Lab Invest, 2008. 88(4): p. 441-9. 
47. Kalantarinia, K., Novel imaging techniques in acute kidney injury. Curr Drug Targets, 
2009. 10(12): p. 1184-9. 
48. Mileto, A., et al., Iodine quantification to distinguish clear cell from papillary renal cell 
carcinoma at dual-energy multidetector CT: a multireader diagnostic performance 
study. Radiology, 2014. 273(3): p. 813-20. 
49. Nilsson, A., Contrast-enhanced ultrasound of the kidneys. Eur Radiol, 2004. 14 Suppl 
8: p. P104-9. 
50. Dunn, K.W., T.A. Sutton, and R.M. Sandoval, Live-animal imaging of renal function by 
multiphoton microscopy. Curr Protoc Cytom, 2012. Chapter 14: p. Unit12 9. 
51. Willekens, I., et al., High-resolution 3D micro-CT imaging of breast microcalcifications: 
a preliminary analysis. BMC Cancer, 2014. 14: p. 9. 
117 
 
 
52. Ehling, J., et al., Micro-CT imaging of tumor angiogenesis: quantitative measures 
describing micromorphology and vascularization. Am J Pathol, 2014. 184(2): p. 431-
41. 
53. Ceulemans, A.G., et al., Serial semiquantitative imaging of brain damage using micro-
SPECT and micro-CT after endothelin-1-induced transient focal cerebral ischemia in 
rats. J Nucl Med, 2011. 52(12): p. 1987-92. 
54. Kampschulte, M., et al., Quantitative 3D micro-CT imaging of human lung tissue. 
Rofo, 2013. 185(9): p. 869-76. 
55. Tapfer, A., et al., Three-dimensional imaging of whole mouse models: comparing 
nondestructive X-ray phase-contrast micro-CT with cryotome-based planar epi-
illumination imaging. J Microsc, 2014. 253(1): p. 24-30. 
56. Easterly, M.E., C.J. Foltz, and M.J. Paulus, Body condition scoring: comparing newly 
trained scorers and micro-computed tomography imaging. Lab Anim (NY), 2001. 
30(3): p. 46-9. 
57. Jorgensen, S.M., O. Demirkaya, and E.L. Ritman, Three-dimensional imaging of 
vasculature and parenchyma in intact rodent organs with X-ray micro-CT. Am J 
Physiol, 1998. 275(3 Pt 2): p. H1103-14. 
58. Lerman, A. and E.L. Ritman, Evaluation of microvascular anatomy by micro-CT. Herz, 
1999. 24(7): p. 531-3. 
59. Vasquez, S.X., N. Shah, and A.M. Hoberman, Small animal imaging and examination 
by micro-CT. Methods Mol Biol, 2013. 947: p. 223-31. 
60. Bennett, K.M., et al., The emerging role of MRI in quantitative renal glomerular 
morphology. Am J Physiol Renal Physiol, 2013. 304(10): p. F1252-7. 
61. Huang, A.J., V.S. Lee, and H. Rusinek, Functional renal MR imaging. Magn Reson 
Imaging Clin N Am, 2004. 12(3): p. 469-86, vi. 
62. Heilmann, M., et al., Quantification of glomerular number and size distribution in 
normal rat kidneys using magnetic resonance imaging. Nephrol Dial Transplant, 2012. 
27(1): p. 100-7. 
63. Beeman, S.C., J.F. Georges, and K.M. Bennett, Toxicity, biodistribution, and ex vivo MRI 
detection of intravenously injected cationized ferritin. Magn Reson Med, 2013. 69(3): 
p. 853-61. 
64. Knopp, M.V., et al., Contrast agents for MRA: future directions. J Magn Reson Imaging, 
1999. 10(3): p. 314-6. 
65. Choyke, P.L. and H. Kobayashi, Functional magnetic resonance imaging of the kidney 
using macromolecular contrast agents. Abdom Imaging, 2006. 31(2): p. 224-31. 
66. Xie, L., et al., Magnetic resonance histology of age-related nephropathy in the 
Sprague Dawley rat. Toxicol Pathol, 2012. 40(5): p. 764-78. 
67. Basgen, J.M., et al., Estimating glomerular number in situ using magnetic resonance 
118 
 
 
imaging and biopsy. Kidney Int, 1994. 45(6): p. 1668-72. 
68. Bertram, J.F., Analyzing renal glomeruli with the new stereology. Int Rev Cytol, 1995. 
161: p. 111-72. 
69. Bertram, J.F., Estimating glomerular number: why we do it and how. Clin Exp 
Pharmacol Physiol, 2013. 40(11): p. 785-8. 
70. Melany, M.L. and E.G. Grant, Clinical experience with sonographic contrast agents. 
Semin Ultrasound CT MR, 1997. 18(1): p. 3-12. 
71. Bertolotto, M., et al., Renal Masses With Equivocal Enhancement at CT: 
Characterization With Contrast-Enhanced Ultrasound. AJR Am J Roentgenol, 2015. 
204(5): p. W557-65. 
72. Okur, A., et al., Relationship between kidney volume and body indexes in the Turkish 
population determined using ultrasonography. Int Braz J Urol, 2014. 40(6): p. 816-22. 
73. Dowling, R.J., et al., Contrast-enhanced Doppler ultrasound for renal artery stenosis. 
Australas Radiol, 1999. 43(2): p. 206-9. 
74. Claudon, M., et al., Renal arteries in patients at risk of renal arterial stenosis: 
multicenter evaluation of the echo-enhancer SH U 508A at color and spectral Doppler 
US. Levovist Renal Artery Stenosis Study Group. Radiology, 2000. 214(3): p. 739-46. 
75. Wei, S., et al., Two- and three-dimensional contrast-enhanced sonography for 
assessment of renal tumor vasculature: preliminary observations. J Ultrasound Med, 
2013. 32(3): p. 429-37. 
76. Garra, B.S., et al., Quantitative ultrasonic detection of parenchymal structural change 
in diffuse renal disease. Invest Radiol, 1994. 29(2): p. 134-40. 
77. Prabahar, M.R., et al., Prediction of tubulo-interstitial injury by Doppler ultrasound in 
glomerular diseases: value of resistive and atrophic indices. J Assoc Physicians India, 
2008. 56: p. 21-6. 
78. Miller, D.L., C. Dou, and R.C. Wiggins, Glomerular capillary hemorrhage induced in 
rats by diagnostic ultrasound with gas-body contrast agent produces intratubular 
obstruction. Ultrasound Med Biol, 2009. 35(5): p. 869-77. 
79. Williams, A.R., et al., Nephron injury induced by diagnostic ultrasound imaging at high 
mechanical index with gas body contrast agent. Ultrasound Med Biol, 2007. 33(8): p. 
1336-44. 
80. Al-Janabi, S., A. Huisman, and P.J. Van Diest, Digital pathology: current status and 
future perspectives. Histopathology, 2012. 61(1): p. 1-9. 
81. Kayser, G. and K. Kayser, Quantitative pathology in virtual microscopy: history, 
applications, perspectives. Acta Histochem, 2013. 115(6): p. 527-32. 
82. Haleem, N.Y., et al., Concomitant protective and therapeutic role of verapamil in 
chronic mercury induced nephrotoxicity in the adult rat: histological, morphometric 
and ultrastructural study. Arch Med Sci, 2015. 11(1): p. 199-209. 
119 
 
 
83. Advani, A., et al., Fluorescent microangiography is a novel and widely applicable 
technique for delineating the renal microvasculature. PLoS One, 2011. 6(10): p. 
e24695. 
84. Debbaut, C., et al., From vascular corrosion cast to electrical analog model for the 
study of human liver hemodynamics and perfusion. IEEE Trans Biomed Eng, 2011. 
58(1): p. 25-35. 
85. Wei, W., et al., Evidence of angiogenesis and microvascular regression in autosomal-
dominant polycystic kidney disease kidneys: a corrosion cast study. Kidney Int, 2006. 
70(7): p. 1261-8. 
86. Yu, X.J., et al., [The SEM observation of brain tissues and vascular corrosion cast of 
closed diffuse brain injuries]. Fa Yi Xue Za Zhi, 1999. 15(1): p. 3-4, 62. 
87. Rummelt, V., et al., Three-dimensional relationships between tumor cells and 
microcirculation with double cyanine immunolabeling, laser scanning confocal 
microscopy, and computer-assisted reconstruction: an alternative to cast corrosion 
preparations. J Histochem Cytochem, 1994. 42(5): p. 681-6. 
88. Giacomini, A., et al., Brain angioarchitecture and intussusceptive microvascular 
growth in a murine model of Krabbe disease. Angiogenesis, 2015. 18(4): p. 499-510. 
89. Vandeghinste, B., et al., Replacing vascular corrosion casting by in vivo micro-CT 
imaging for building 3D cardiovascular models in mice. Mol Imaging Biol, 2011. 13(1): 
p. 78-86. 
90. Wagner, R., et al., High-resolution imaging of kidney vascular corrosion casts with 
Nano-CT. Microsc Microanal, 2011. 17(2): p. 215-9. 
91. Snyder, S. and B. Pendergraph, Detection and evaluation of chronic kidney disease. 
Am Fam Physician, 2005. 72(9): p. 1723-32. 
92. Grenier, N., M. Pedersen, and O. Hauger, Contrast agents for functional and cellular 
MRI of the kidney. Eur J Radiol, 2006. 60(3): p. 341-52. 
93. Grenier, N., et al., Functional MRI of the kidney. Abdom Imaging, 2003. 28(2): p. 164-
75. 
94. Hynes, A., et al., Molecular mapping of periodontal tissues using infrared 
microspectroscopy. BMC Med Imaging, 2005. 5(1): p. 2. 
95. Baker, M.J., et al., Using Fourier transform IR spectroscopy to analyze biological 
materials. Nat Protoc, 2014. 9(8): p. 1771-91. 
96. Petibois, C. and G. Deleris, Chemical mapping of tumor progression by FT-IR imaging: 
towards molecular histopathology. Trends Biotechnol, 2006. 24(10): p. 455-62. 
97. Mantsch, H.H. and D. Chapman, Infrared spectroscopy of biomolecules. 1996, New 
York: Wiley-Liss. xi, 359 p. 
98. Haris, P.I. and D. Chapman, The conformational analysis of peptides using Fourier 
transform IR spectroscopy. Biopolymers, 1995. 37(4): p. 251-63. 
120 
 
 
99. Mordechai, S., et al., Possible common biomarkers from FTIR microspectroscopy of 
cervical cancer and melanoma. J Microsc, 2004. 215(Pt 1): p. 86-91. 
100. Kole, M.R., et al., Discrete frequency infrared microspectroscopy and imaging with a 
tunable quantum cascade laser. Anal Chem, 2012. 84(23): p. 10366-72. 
101. Kroger-Lui, N., et al., Rapid identification of goblet cells in unstained colon thin 
sections by means of quantum cascade laser-based infrared microspectroscopy. 
Analyst, 2015. 140(7): p. 2086-92. 
102. Tobin, M.J., et al., Infrared microscopy of epithelial cancer cells in whole tissues and in 
tissue culture, using synchrotron radiation. Faraday Discuss, 2004. 126: p. 27-39; 
discussion 77-92. 
103. Martin, M.C., et al., 3D spectral imaging with synchrotron Fourier transform infrared 
spectro-microtomography. Nat Methods, 2013. 10(9): p. 861-4. 
104. Nasse, M.J., et al., High-resolution Fourier-transform infrared chemical imaging with 
multiple synchrotron beams. Nat Methods, 2011. 8(5): p. 413-6. 
105. Dorling, K.M. and M.J. Baker, Rapid FTIR chemical imaging: highlighting FPA 
detectors. Trends Biotechnol, 2013. 31(8): p. 437-8. 
106. Bhargava, R., Infrared spectroscopic imaging: the next generation. Appl Spectrosc, 
2012. 66(10): p. 1091-120. 
107. Bellisola, G. and C. Sorio, Infrared spectroscopy and microscopy in cancer research 
and diagnosis. Am J Cancer Res, 2012. 2(1): p. 1-21. 
108. Matthaus, C., et al., Chapter 10: Infrared and Raman microscopy in cell biology. 
Methods Cell Biol, 2008. 89: p. 275-308. 
109. Petter, C.H., et al., Development and application of Fourier-transform infrared 
chemical imaging of tumour in human tissue. Curr Med Chem, 2009. 16(3): p. 318-26. 
110. Malins, D.C., et al., The etiology and prediction of breast cancer. Fourier transform-
infrared spectroscopy reveals progressive alterations in breast DNA leading to a 
cancer-like phenotype in a high proportion of normal women. Cancer, 1995. 75(2): p. 
503-17. 
111. Malins, D.C., N.L. Polissar, and S.J. Gunselman, Tumor progression to the metastatic 
state involves structural modifications in DNA markedly different from those 
associated with primary tumor formation. Proc Natl Acad Sci U S A, 1996. 93(24): p. 
14047-52. 
112. Petibois, C. and B. Desbat, Clinical application of FTIR imaging: new reasons for hope. 
Trends Biotechnol, 2010. 28(10): p. 495-500. 
113. Tiwari, S. and R. Bhargava, Extracting knowledge from chemical imaging data using 
computational algorithms for digital cancer diagnosis. Yale J Biol Med, 2015. 88(2): p. 
131-43. 
114. Fernandez, D.C., et al., Infrared spectroscopic imaging for histopathologic recognition. 
121 
 
 
Nat Biotechnol, 2005. 23(4): p. 469-74. 
115. Mitchell, A.L., et al., Vibrational spectroscopy of biofluids for disease screening or 
diagnosis: translation from the laboratory to a clinical setting. J Biophotonics, 2014. 
7(3-4): p. 153-65. 
116. Gajjar, K., et al., Fourier-transform infrared spectroscopy coupled with a classification 
machine for the analysis of blood plasma or serum: a novel diagnostic approach for 
ovarian cancer. Analyst, 2013. 138(14): p. 3917-26. 
117. Ollesch, J., et al., FTIR spectroscopy of biofluids revisited: an automated approach to 
spectral biomarker identification. Analyst, 2013. 138(14): p. 4092-102. 
118. Bhargava, R., et al., High throughput assessment of cells and tissues: Bayesian 
classification of spectral metrics from infrared vibrational spectroscopic imaging data. 
Biochim Biophys Acta, 2006. 1758(7): p. 830-45. 
119. Reddy, R.K. and R. Bhargava, Accurate histopathology from low signal-to-noise ratio 
spectroscopic imaging data. Analyst, 2010. 135(11): p. 2818-25. 
120. Noreen, R., et al., Functional histology of glioma vasculature by FTIR imaging. Anal 
Bioanal Chem, 2011. 401(3): p. 795-801. 
121. Bobroff, V., et al., FTIR spectroscopy characterization of fatty-acyl-chain conjugates. 
Anal Bioanal Chem, 2015. 
122. Nichols, E.F., A study of the transmission spectra of certain substances in the infrared. 
Physical Rev, 1893. 1(1): p. 1-18. 
123. Coblentz, W.W., Investigations of Infrared Spectra, in Carnegie Institute of 
Washington, T.P.P.N.M. USA, Editor. 1905: Washington D.C. p. 1-190. 
124. Ambrose, E.J. and A. Elliott, Infra-red spectra and structure of fibrous proteins. 
Proceedings of the Royal Society of London, 1951. 260: p. 206-219. 
125. Naumann, D., D. Helm, and H. Labischinski, Microbiological characterizations by FT-IR 
spectroscopy. Nature, 1991. 351(6321): p. 81-2. 
126. Petibois, C., et al., Determination of glucose in dried serum samples by Fourier-
transform infrared spectroscopy. Clin Chem, 1999. 45(9): p. 1530-5. 
127. Budinova, G., J. Salva, and K. Volka, Application of molecular spectroscopy in the mid-
infrared region to the determination of glucose and cholesterol in whole blood and in 
blood serum. Appl Spectrosc, 1997. 51(5): p. 631-5. 
128. Ward, K.J., et al., Quantitative infrared spectroscopy of glucose in blood using partial 
least-squares analyses. SPIE: Fourier Transform Spectroscopy, 1989. 1145: p. 607-8. 
129. Petibois, C., et al., Plasma protein contents determined by Fourier-transform infrared 
spectrometry. Clin Chem, 2001. 47(4): p. 730-8. 
130. Petibois, C., et al., Differentiation of populations with different physiologic profiles by 
plasma Fourier-transform infrared spectra classification. J Lab Clin Med, 2001. 137(3): 
p. 184-90. 
122 
 
 
131. Barer, R., A.R.H. Cole, and H.W. Thompson, Infra-Red Spectroscopy with the Reflecting 
Microscope in Physics, Chemistry and Biology. Nature, 1949. 163: p. 198-201. 
132. Innocenzi, P., et al., Time-resolved infrared spectroscopy as an in situ tool to study the 
kinetics during self-assembly of mesostructured films. J Phys Chem B Condens Matter 
Mater Surf Interfaces Biophys, 2006. 110(22): p. 10837-41. 
133. Petibois, C. and M. Cestelli Guidi, Bioimaging of cells and tissues using accelerator-
based sources. Anal Bioanal Chem, 2008. 391(5): p. 1599-608. 
134. Petibois, C., et al., A bright future for synchrotron imaging. Nat Photonics, 2009. 3(4): 
p. 179. 
135. Petibois, C., et al., Synchrotron radiation FTIR imaging in minutes: a first step towards 
real-time cell imaging. Anal Bioanal Chem, 2010. 397(6): p. 2123-9. 
136. Petibois, C., et al., Facing the challenge of biosamples FTIR imaging using the 
synchrotron radiation source. J Synhrotron Rad, 2010. 17(1): p. 1-11. 
137. Drogat, B., et al., Acute L-Glutamine Deprivation Compromises VEGF-A Up-regulation 
in A549/8 Human Carcinoma Cells. J Cell Physiol, 2007. 212(8): p. 463-72. 
138. Petibois, C., Imaging methods for elemental, chemical, molecular, and morphological 
analyses of single cells. Anal Bioanal Chem, 2010. 397(6): p. 2051-2065. 
139. Cestelli Guidi, M., et al., Experimental ATR device for real-time SR-FTIR imaging of 
living cells. Biotechnol Adv, 2013. 31: p. 402-7. 
140. Petibois, C., et al., Analytical performances of FT-IR spectrometry and imaging for 
concentration measurements within biological fluids, cells, and tissues. Analyst, 2006. 
131(5): p. 640-7. 
141. Levenson, E., P. Lerch, and M.C. Martin, Spatial resolution limits for synchrotron-
based infrared microspectroscopy. Infrared Phys Technol, 2008. 51(5): p. 413-16. 
142. Fabian, H., P. Lasch, and D. Naumann, Analysis of biofluids in aqueous environment 
based on mid-infrared spectroscopy. J Biomed Opt, 2005. 10(3): p. 031103. 
143. Cestelli-Guidi, M., et al., Optical performances of SINBAD, the Synchrotron INfrared 
Beamline At DAPHNE. J Opt Soc Am A, 2005. 22(12): p. 2810-7. 
144. Petibois, C., et al., Method for determining absorption bands, Inserm, Editor. 2014: 
France. 
145. Petibois, C., Imaging techniques with synchrotron radiation. Anal Bioanal Chem, 2010. 
397(6): p. 2031-2032. 
146. Mayet, C., et al., Analysis of bacterial polyhydroxybutyrate production by multimodal 
nanoimaging. Biotechnol Adv, 2013. 31(3): p. 369-74. 
147. Ghosh, S., et al., Conducting polymer nanostructures for photocatalysis under visible 
light. Nat Mater, 2015. 14(5): p. 505-11. 
148. Houel, J., et al., Midinfrared absorption measured at a lambda/400 resolution with an 
atomic force microscope. Opt Express, 2009. 17(13): p. 10887-94. 
123 
 
 
149. Petibois, C., The emergence of multimodal imaging methods for real-time nanoscopy. 
Anal Bioanal Chem, 2011. 399. 
150. Coresh, J., et al., Prevalence of chronic kidney disease and decreased kidney function 
in the adult US population: Third National Health and Nutrition Examination Survey. 
Am J Kidney Dis, 2003. 41(1): p. 1-12. 
151. Keith, D.S., et al., Longitudinal follow-up and outcomes among a population with 
chronic kidney disease in a large managed care organization. Arch Intern Med, 2004. 
164(6): p. 659-63. 
152. Puelles, V.G., et al., Glomerular hypertrophy in subjects with low nephron number: 
contributions of sex, body size and race. Nephrol Dial Transplant, 2014. 29(9): p. 1686-
95. 
153. Amharref, N., et al., Brain tissue characterisation by infrared imaging in a rat glioma 
model. Biochim Biophys Acta, 2006. 1758(7): p. 892-9. 
154. Wood, B.R., et al., Fourier transform infrared (FTIR) spectral mapping of the cervical 
transformation zone, and dysplastic squamous epithelium. Gynecol Oncol, 2004. 
93(1): p. 59-68. 
155. Lasch, P. and D. Naumann, FT-IR microspectroscopic imaging of human carcinoma 
thin sections based on pattern recognition techniques. Cell Mol Biol (Noisy-le-grand), 
1998. 44(1): p. 189-202. 
156. Dreissig, I., et al., Quantification of brain lipids by FTIR spectroscopy and partial least 
squares regression. Spectrochim Acta A Mol Biomol Spectrosc, 2009. 71(5): p. 2069-
75. 
157. Paschalis, E.P., et al., FTIR microspectroscopic analysis of normal human cortical and 
trabecular bone. Calcif Tissue Int, 1997. 61(6): p. 480-6. 
158. Noreen, R., et al., FTIR spectro-imaging of collagen scaffold formation during glioma 
tumor development. Anal Bioanal Chem, 2013. 405(27): p. 8729-36. 
159. Spalazzi, J.P., et al., Quantitative mapping of matrix content and distribution across 
the ligament-to-bone insertion. PLoS One, 2013. 8(9): p. e74349. 
160. Noreen, R., et al., Detection of collagens in brain tumors based on FTIR imaging and 
chemometrics. Anal Bioanal Chem, 2011. 401(3): p. 845-52. 
161. Majzner, K., et al., Secondary structure of proteins analyzed ex vivo in vascular wall in 
diabetic animals using FT-IR spectroscopy. Analyst, 2013. 138(24): p. 7400-10. 
162. Saeed, A., et al., Effects of Very Low Dose Fast Neutrons on Cell Membrane And 
Secondary Protein Structure in Rat Erythrocytes. PLoS One, 2015. 10(10): p. 
e0139854. 
163. Leskovjan, A.C., A. Kretlow, and L.M. Miller, Fourier transform infrared imaging 
showing reduced unsaturated lipid content in the hippocampus of a mouse model of 
Alzheimer's disease. Anal Chem, 2010. 82(7): p. 2711-6. 
124 
 
 
164. Wood, B.R., et al., A three-dimensional multivariate image processing technique for 
the analysis of FTIR spectroscopic images of multiple tissue sections. BMC Med 
Imaging, 2006. 6: p. 12. 
165. Nagle, R.B., et al., Unilateral obstructive nephropathy in the rabbit. I. Early 
morphologic, physiologic, and histochemical changes. Lab Invest, 1973. 28(4): p. 456-
67. 
166. Chevalier, R.L., M.S. Forbes, and B.A. Thornhill, Ureteral obstruction as a model of 
renal interstitial fibrosis and obstructive nephropathy. Kidney Int, 2009. 75(11): p. 
1145-52. 
167. Wilson, D.R., Renal function during and following obstruction. Annu Rev Med, 1977. 
28: p. 329-39. 
168. Kawada, N., et al., Increased oxidative stress in mouse kidneys with unilateral ureteral 
obstruction. Kidney Int, 1999. 56(3): p. 1004-13. 
169. Massy, Z.A. and T. Nguyen-Khoa, Oxidative stress and chronic renal failure: markers 
and management. J Nephrol, 2002. 15(4): p. 336-41. 
170. Cracowski, J.L., T. Durand, and G. Bessard, Isoprostanes as a biomarker of lipid 
peroxidation in humans: physiology, pharmacology and clinical implications. Trends 
Pharmacol Sci, 2002. 23(8): p. 360-6. 
171. Buhrle, C.P., et al., The hydronephrotic kidney of the mouse as a tool for intravital 
microscopy and in vitro electrophysiological studies of renin-containing cells. Lab 
Invest, 1986. 54(4): p. 462-72. 
172. Tanner, G.A. and L.C. Knopp, Glomerular blood flow after single nephron obstruction 
in the rat kidney. Am J Physiol, 1986. 250(1 Pt 2): p. F77-85. 
 
 
